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The International Epidemiological Transition
and the Education Gender Gap




We explore the impact of the international epidemiological transition on edu-
cational attainment of males and females over the second half of the 20th century
using an instrumental variables strategy that exploits pre-existing variation in mor-
tality rates across infectious diseases and gender di¤erences in the responsiveness of
the immune system to vaccination. We document that health improvements associ-
ated with the transition led to larger gains in female life expectancy. These relative
gains were associated with relative increases in female educational attainment and
account for a large share of the reduction in the education gender gap that took
place over this period.
Keywords: International Epidemiological Transition, Vaccination, Life Expectancy,
Education, Gender Di¤erences, Economic Development.
JEL Classication: I15, I24, J16, O11.
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1 Introduction
One of the greatest achievements of the world during the 20th century has been the
progress made towards gender equality. Comparing the role of women in economic and
social life in 2000 relative to that in 1900 reveals the remarkable changes that have
happened in terms of womens legal status, political rights, access to the labor market,
and other areas. Nowhere is this change more visible, though, than when looking at female
educational attainment. In many countries of the world women nowadays outperformmen
in all levels of education, to the point that the relative under-performance of men is being
considered an emerging problem (OECD, 2015).
The progress achieved toward the closing of the gender gap in education can be seen
in Figure 1. The gure depicts for a broad sample of 146 countries the evolution of the
female-to-male ratio of average years of schooling over the 20th century based on data
from Barro and Lee (2013). In the beginning of the century this ratio uctuated around
0.75, implying that females had on average only 3/4 of the years of schooling of males.
Starting from around the 1950s, though, we see a clear upward trend in this ratio, which
eventually resulted in the complete elimination of the female gap in education in most
countries of the world.
[Insert Figure 1 around here]
Understanding the driving forces behind this remarkable transition has been the focus
of a growing literature in economics. Early contributions by Goldin (1995), Galor and
Weil (1996), as well as Goldin et al. (2006) have stressed the role of improved labor
market opportunities for women. More recent work by Chiappori et al (2009), Fernandez
and Wong (2011), and Reijnders (2017) have highlighted changes in marriages patterns as
an important factor. Greenwood et al. (2016) have stressed the role of the decline in the
price of household durables, which freed women from household work, while Fernández,
Fogli and Olivetti (2004), Beaman et al. (2012) and Fernández (2013) have emphasized
the importance of changing norms regarding the role of women in society. The literature
has also explored the role of medical innovations such as the introduction of the birth
control pill (Goldin and Katz, 2002) and improvements in maternal health (Albanesi
and Olivetti, 2016) in raising female schooling. Overall, however, most of the existing
contributions have focused on the experiences of developed countries and particularly on
the case of the United States.
Yet, developed countries may not provide the most striking examples in terms of the
evolution of the education gender gap. As Figure 2 demonstrates, the relative rise in
female educational attainment over the second half of the 20th century has been much
more rapid in developing countries, where many of the aforementioned factors have played
a less important role. Countries such as Bolivia, China, Congo, Egypt, India, Indonesia
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and Turkey, despite their big di¤erences in terms of economic development, all witnessed
a closing of the gender gap since the 1940s. With that in mind, in this paper we study
the evolution of the education gender gap in a broad sample of countries and consider the
role of general improvements in health as a driving force behind the observed transition.
In this context, we demonstrate that the closing of the education gender gap can largely
be attributed to di¤erential health improvements between men and women.
[Insert Figure 2 around here]
Exploring the link between health improvements and educational attainment, al-
though not central in the gender gap literature, is natural as health improvements have
commonly been argued to promote educational attainment. Healthier individuals, who
expect to live longer, are bound to have stronger incentives to invest in their own edu-
cation as well as in that of their children. The nature of this link has been highlighted
in a series of theoretical models starting with Ben-Porath (1967) and more recent contri-
butions by Boucekkine et al. (2002), Kalemli-Ozcan (2002), Cervellati and Sunde (2005,
2015), Soares (2005) and de la Croix and Licandro (2012). At the same time Soares
(2006), Bleakley (2007), Jayachandran and Lleras-Muney (2009), Lucas (2010), Oster et
al. (2013), and Hansen and Strulik (2017) have provided empirical evidence in support
of this association.
Following the conclusions from this literature, we would expect that a reduction in
the education gender gap would result from relatively faster increases in female education
triggered by relatively stronger improvements in female health. As shown in Table 1, a
simple comparison of the evolution of educational attainment of males and females and
life expectancy at birth over the 20th century indeed suggests this pattern. While up
until the 1950s the di¤erences between males and females in terms of life expectancy and
average years of schooling were fairly constant, in the years that followed we see relative
female life expectancy rising sharply and the education gender gap declining.
[Table 1 around here]
As the similarity in the time trends of relative female life expectancy and education
is only suggestive, in our analysis we explore more carefully the link between the two by
exploiting exogenous variation in life expectancy gains triggered by the so-called Inter-
national Epidemiological Transition (IET). This term refers to a period of rapid decline
in mortality from previously highly fatal infectious diseases which started after the end
of World War II and resulted in unprecedented improvements in life expectancy around
the globe (Becker et al., 2005; Cutler et al.,2006). These improvements were brought
forward by a sequence of important medical innovations related to the development of
antibiotics, vaccines and other treatment methods. Largely products of medical research
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in developed countries, these innovations di¤used quickly around the globe as a result
of the coordinated e¤orts of the United Nations and the World Health Organization.
The consequence of this di¤usion process was the almost complete eradication of many
infectious diseases, which previously had a¤ected large shares of the worlds population,
within a few decades.
In this historical context and following a line of research pioneered by Acemoglu and
Johnson (2007), we estimate the impact of life expectancy improvements, triggered by
the global spread of the new medical innovations, on educational attainment of males and
females in an instrumental variables regression setup. For this purpose we use variation
in the disease environment across countries prior to onset of the IET, as the introduction
of the new treatment methods naturally had a large impact in places where mortality
from infectious diseases was initially higher. In contrast to existing work that has studied
the aggregate e¤ects of the IET for the overall population (Acemoglu and Johnson, 2007;
Cervellati and Sunde, 2011; Hansen, 2013 ), however, we consider the di¤erential impact
that the new medical technologies had on males and females, an important dimension
that the literature has until now largely overlooked. In particular, we demonstrate that
women beneted more in terms of life expectancy from the medical innovations associated
with the IET than men. This in turn resulted in di¤erential increases in female and male
educational attainment and contributed to a sizeable reduction in the education gender
gap.
Exploring the nature of these gender-specic e¤ects of the IET on life expectancy, we
show that they are rooted in the di¤erential biological responses of males and females
to vaccination. This nding relates to a recent medical literature which has documented
that females exhibit stronger immune responses to vaccines than men (Cook, 2008; Klein
et al., 2010; Furman et al., 2013). As a consequence of that, vaccines are more e¤ective
in providing disease protection for women compared to men. On the other hand, no such
di¤erences have so far been documented for antiviral and antibacterial drugs. In light
of this evidence, we explore the extent to which the mortality reductions were due to
vaccine- or non-vaccine-related medical innovations. Separating mortality improvements
along these lines, we document that women experienced larger increases in life expectancy
and educational attainment than men specically in countries were the IET brought forth
mortality reductions in infectious diseases that became preventable with vaccines. We also
highlight the absence of such di¤erential e¤ects in countries where mortality reductions
were primarily achieved for diseases for which vaccines did not constitute an e¤ective
method of control.
Taking into account both the gender- and the disease-specic characteristics of the
IET allows us to explain a sizeable share of the reduction in the education gender gap that
occurred across countries between 1940 and 1980. Based on the estimated magnitudes
for the above described e¤ects we are able to explain 39% of the actual life expectancy
4
increases of women and 33% of those of men. In terms of educational attainment, the
estimated e¤ects can account for 26% and 21% of the observed increases in female and
male education. These di¤erential increases in male and female education in turn imply
that the di¤erential impacts of the medical innovations associated with the IET on male
and female health can account for 80% of the observed global reductions in the education
gender gap between 1940 and 1980.
Going one step further, we also study the broader macroeconomic implications of these
di¤erential improvements in male and female health. In this context we provide evidence
that the negative association between GDP per capita and life expectancy reported by
Acemoglu and Johnson (2007) occurred largely in countries where the relative increases
in female life expectancy over this period were small. Furthermore, we show that the
positive e¤ects of the post-1940 life expectancy gains on income per capita documented
by Cervellati and Sunde (2011) for countries that had already undergone the demographic
transition were concentrated among countries where female life expectancy rose more than
male life expectancy. Overall these results suggest that female health improvements can
have an important positive contribution to economic development.
To establish these results we proceed as follows. Section 2 reviews the evidence from
the medical literature on gender di¤erences in the context of infectious diseases. Section
3 outlines the empirical strategy that we follow in the paper. Section 4 describes the
data that we use. Section 5 presents our baseline results regarding the e¤ect of life
expectancy on educational attainment, while their robustness is assessed in Section 6.
Section 7 presents evidence regarding the e¤ects of improvements in male and female life
expectancy on GDP per capita. Section 7 o¤ers some concluding remarks.
2 Gender Di¤erences related to Infectious Diseases
Since Grossman (1985), the medical literature has recognized that immune responses to
pathogens di¤er for men and women. Men generally show weaker immune responses
than women, making them more susceptible to contract infectious diseases and having
more severe disease outcomes compared to women. In this section we summarize the key
evidence regarding the di¤erent ways in which men and women are a¤ected by infectious
diseases and how they respond to vaccination. These gender di¤erences are later on
explored in our empirical analysis.1
In their review of recent epidemiological studies, Bernin and Lotter (2014) document
that parasitic diseases, such as malaria, a¤ect men more frequently and more severely than
women. Neyrolles and Quintana-Murci (2009) and Nhamoyebonde and Leslie (2014) show
that males are also more frequently a¤ected by tuberculosis compared to females, with
1As this paper relates biological di¤erences between men and women to educational outcomes in a
given social context, we use the terms sexand genderinterchangeably to refer to these di¤erences.
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the male-to-female ratio being 1.9 based on case notications. Muenchho¤ and Gouldner
(2014) discuss gender di¤erences in pediatric infectious diseases and provide evidence
that males have typically higher disease susceptibility as well as higher morbidity and
mortality than females. Gieng-Kroell et al. (2015) review the evidence on the e¤ect of
24 infectious diseases on adults and report a male bias for 54% of the diseases in terms
of incidences and of 57% of the diseases in terms of mortality.
Looking at broader sets of data on mortality rates from infectious diseases also indi-
cates the presence of a male bias. Owens (2002) provides some evidence for this using
data from the United States, while Lozano et al. (2012) demonstrate it based on the
Global Burden of Disease Study. In particular, Lozano et al. estimate sex-specic mor-
tality rates for 235 causes of deaths based on vital statistics from 187 countries between
1990 and 2010. These data show that across the 27 most important infectious diseases
male mortality rates are on average 13% higher than the corresponding rates for females.
Only ve out of the 27 major diseases show a slight female bias, while in four cases the
mortality rates appear to be the same for males and females.
Looking at the age-specic nature of the reported male bias, the existing evidence
suggests that the bias is driven largely by physiological di¤erences related to sex hor-
mones. In the case of parasitic diseases, Bernin and Lotter (2014) provide evidence
that the higher disease susceptibility of males relative to females tends to peak during
middle ages, following the increase in testosterone levels. Similarly, Guerra-Silveira and
Abad-Franch (2013) document that the male bias in disease incidence for most pathogens
typically rst emerges during the rst year of life. This coincides with the surge of sex
hormones during the so-called mini-puberty. It then falls during early childhood when
hormonal di¤erences are minimal and peaks again during puberty and reproductive ages
when the variation in sex hormone levels between males and females is highest. Moreover,
the authors report that exposure to pathogens is typically sex-unbiased, indicating that
the observed male bias in disease susceptibility and mortality is unrelated to behavioral or
environmental factors.2 Suggestive evidence for the physiological nature of the male bias
in infectious diseases and the role of hormones is also provided by specic case studies
among humans. For example, Hamilton and Mestler (1969) show that castrated males
have a lower mortality rate from tuberculosis than males with intact genitalia. Similarly,
Svanberg (1981) nds that women who underwent surgical removal of the ovaries have
higher rates of tuberculosis mortality than the overall female population.
The conclusion that the male bias in disease susceptibility and mortality from infec-
tious diseases is due to variation in sex hormones has also been strongly supported by
laboratory experiments with animals. Such experiments have shown, for instance, that
2In addition to variation in sex hormones, there is also some evidence that genetic factors related to
the X-chromose may play a role in explaining the sex bias in tuberculosis prevalence. See for example
Baghdadi et al. (2006) and Davila et al. (2008).
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treatment of female mice with testosterone reduces their resistance to parasites and in-
creases their disease burden (Cernetitch et al., 2006), whereas castration renders male
mice more resistant (Wunderlich et al., 2002; Krucken et al., 2005). For the case of tu-
berculosis, Yamamoto et al. (1991) have shown that male mice are more susceptible to
infections and develop more severe disease outcomes. Just like in the above case, the au-
thors provide evidence that castration increases resistance to the disease, while treatment
with testosterone reduces it. In a similar vein, Tsuyuguchi et al. (2001) have shown that
female mice whose ovaries had been removed exhibit lower resistance to the tuberculosis
bacterium than control mice that underwent placebo surgery. Moreover, treatment with
estrogen of the female mice without ovaries was shown to restore disease resistance to the
same level as in the control group of mice.
More recent studies have documented that such di¤erences between males and fe-
males characterize also their responses to vaccines against infectious diseases. This was
rst documented by Stanberry et al. (2002) and Cook (2008). These studies demonstrate
that vaccine e¢ cacy, namely the relative reduction in disease susceptibility of a vacci-
nated group of individuals compared to an non-vaccinated one, is signicantly higher for
women. While Stanberry focused on the case of herpes vaccines, Cook demonstrated
that this pattern can be observed both for viral as well as for common bacterial diseases.
Their ndings have also been conrmed in a series of replication studies by Klein et al.
(2010), Klein and Pekosz (2014) and Klein et al. (2015). These authors document that
disease protection from vaccines is stronger among women for several common infectious
diseases.3 These di¤erences in vaccine e¢ cacy have also been shown to be substantial.
For example, Klein et al. (2010) show that in the case of inuenza women exhibit the
same antibody response to half a dose of the vaccine compared to a full dose in men.
It is important to note here that this pattern is not due to di¤erences in the vaccine
doses administered to men and women. In fact, the standard medical practice is to
universally administer the same dose (Poland et al., 2008a), irrespective of sex. Instead,
as in the case of the male bias in disease susceptibility, the evidence suggests that these
di¤erences should be attributed to sex hormones, especially estrogens (Klein et al., 2010)
and testosterone (Furman et al., 2013). In fact, estrogens have been shown to stimulate
the activity of immune cells more generally, while testosterone has been shown to suppress
it (Fish, 2008; Gieng-Kroell et al., 2015). As such, the stronger immune response to
vaccines in women is in line with women being less susceptible to contract infectious
diseases and having less severe disease outcomes, as discussed above. This is because sex
hormones and genetic di¤erences not only inuence the functioning of immune cells in
response to vaccines, but also a¤ect the response to naturally occurring pathogens (Cook,
2008; Fish, 2008).
3These diseases include herpes, hepatitis, inuenza, measles, mumps, rubella, smallpox, tuberculosis
and yellow fever.
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These stark gender di¤erences in the e¤ectiveness of vaccination against infectious
diseases contrasts with the case of other treatments methods. In fact, for antivirals,
antibiotics and other drugs acting on the immune system there is no similar evidence
of clear di¤erences in the responses of males and females. Only for drugs acting on the
central nervous system, such as anti-psychotic drugs and antidepressant, as well as beta-
blockers reducing the heart rate and systolic blood pressure there is weak evidence for
more benecial e¤ects on women compared to men (Franconi et al., 2007).
Overall these medical studies underscore an important pattern: Immune responses of
men and women to infectious diseases are di¤erent and this is true for both exposure to
the naturally occurring pathogen as well as to the associated vaccine. These di¤erences
do not appear to be driven by behavior, but are rooted in biological di¤erences related
to sex hormones. This suggests that vaccination campaigns will give rise to di¤erential
e¤ectiveness across genders.4 In particular, vaccination campaigns against infectious
diseases are expected to trigger larger mortality reductions for females than for males,
while this is not expected to be the case for other public health interventions aimed at
controlling infectious diseases which do not rely on vaccination. In the following section
we describe how we are going to exploit this pattern in the context of our empirical
strategy.
3 Empirical Strategy
Our empirical strategy builds on the approach of Becker et al. (2005), and Acemoglu and
Johnson (2007) who investigate the macroeconomic e¤ects of the large improvements
in life expectancy that took place over the second half of 20th century. In particular,
we explore the fact that countries where the mortality burden from infectious diseases
was higher before the onset of the IET were the ones that beneted more in terms of
mortality reductions from the new treatment methods that became available globally after
the 1940s. Following the identication strategy proposed by Acemoglu and Johnson, we
exploit the exogenous nature of the initial di¤erences in mortality rates from infectious
diseases to identify the impact of the subsequent changes in life expectancy on educational
attainment in an instrumental variables regression.
Our analysis, however, di¤ers from previous contributions in the literature, as we
investigate the gender-specic nature of the improvements in life expectancy and their
e¤ect on educational attainment. Specically, we take into consideration whether the
initial mortality environment in a given country was dominated by infectious diseases
4This is provided that these campaigns are equally e¤ective at targeting males and females. As
documented in World Bank (2012), though, there is no evidence for gender discrimination in the use of
preventative health services, such as vaccination. Even in a country like India with very unequal gender
norms vaccination rates do not appear to di¤er between boys and girls (Banerjee et al., 2010).
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that were subsequently controlled by vaccination or by other prevention methods, such
as the use of antibiotics. This strategy allows us to exploit the fact that di¤erent health
campaigns aimed at controlling infectious diseases have had di¤erent e¤ects on males and
females, as discussed in the previous section.
With the global spread of western medical technologies in the post-war era, most
infectious diseases became preventable and mortality rates from these diseases fell sub-
stantially around the world. Yet, this e¤ect was not uniform for males and females. In
countries where the mortality environment prior to 1940 was dominated by infectious
diseases that subsequently became preventable thanks to the introduction of new or im-
proved vaccines we would expect to see a stronger increase in life expectancy for females
than for males. In contrast, in countries where the mortality environment prior to 1940
was dominated by infectious diseases that subsequently became preventable thanks to
other medical innovations we would expect to see similar increases in female and male
life expectancy.
Exploiting this pattern, we estimate the impact of changes in life expectancy of males
and females on their educational attainment in a long-di¤erences panel between two time
periods, which for most of our analysis we take to be 1940 and 1980. Specically, our
baseline estimation equation is the following:
AY Sgct =   LEgct + gc + t + ugct: (1)
Here AY Sgct denotes the average years of schooling of a given cohort of gender g in
country c in year t and LEgct denotes the life expectancy at birth of gender group g in
country c at time t. The specication includes gender-country xed e¤ects, gc; and year
xed e¤ects t: Conditional on these xed e¤ects, a positive  coe¢ cient would suggest
that life expectancy improvements for a given cohort are associated with increases in the
years of schooling attained on average by that cohort.
To account for the potential endogeneity bias in the estimation of ; we use a two-
stage least square (2SLS) estimation procedure where we instrument LEgct in equation





V f  Ifg 
P
d2V
Mdct + : : :
: : :+ NV P
d2NV
Mdct + 
NV f  Ifg 
P
d2NV
Mdct + gc + t + "gct:
(2)
The subscripts g; c; and t again denote gender, country, and year, while the index d
denotes di¤erent infectious diseases. Thus, Mdct is the mortality rate from infectious
disease d in country c and year t, which, following Acemoglu and Johnson (2007), we
take to be equal to the actual country-specic values in 1940 and the mortality rate at
the global health frontier in 1980. As Mdct takes the same values for all countries in
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1980, the variable does not capture actual changes in mortality over time for disease d
and the pace at which the disease was eradicated. Instead it reects predicted changes in
mortality from a given infectious disease that followed as a consequence of the newmedical
innovations and their global di¤usion after 1940. Thus, changes in Mdct are treated as
an predictor for the actual changes in mortality from infectious diseases that occurred
across countries and genders between 1940 and 1980 and are used as an instrument for
the associated changes in life expectancy.
These mortality rates are then aggregated into two groups. A group of vaccine-
preventable diseases, which we denote as V and refer to as the V-disease group, and a
group of non-vaccine-preventable diseases, which we denote asNV and refer to as the NV-
disease group. The aggregate mortality rates for these two groups are interacted with a
dummy variable for all female observations, Ifg ; in order to estimate the di¤erential e¤ects
of the predicted mortality reductions across genders. The specication also includes
gender-country and year xed e¤ects in line with equation (1).
As larger changes inMdct over time indicate greater predicted reductions in mortality
from infectious diseases of a given group, they should be associated with larger increases
in life expectancy. Thus, we would expect both V and NV to be negative. Comparing
these e¤ects across males and females, we would expect the interaction coe¢ cient V f to
be negative. This is because, in light of the medical evidence presented above, reductions
in mortality from infectious diseases that became preventable with the introduction of
new vaccines are bound to be larger for females. On the other hand, as there is no
expectation for larger increases in female life expectancy from reductions in mortality
from non-vaccine-preventable infectious diseases, we expect the interaction coe¢ cient
NV f to be zero.
The unbiased estimation of the key coe¢ cients of interest in our empirical setup re-
quires the exogeneity of the employed predicted mortality changes for the di¤erent groups
of infectious diseases. In that respect, the crucial assumption is that the initial mortal-
ity rates, which reect the mortality environment in each country prior to the IET, are
uncorrelated with other time-varying country and gender specic characteristics that in-
uence education through channels other than life expectancy. To ensure the validity of
this assumption, as part of our robustness analysis, we control for several time-varying
correlates of male and female health and educational attainment, the omission of which
could bias our results. Other factors leading to persistent di¤erences in the level of edu-
cational attainment of males and females in a given country are not explicitly controlled
for in our regression as they will be ltered out by the gender-country xed e¤ects.5
5Such di¤erences could be related to the the relative status of women in society as well as to their
relative access to health care and schooling.
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4 Data
Our estimation is based on a panel data set covering 75 countries in two time periods.
As already mentioned in the previous section, for our baseline regressions the two time
periods correspond to the years 1940 and 1980.6 We focus on changes in education, life
expectancy and mortality between these two time periods in order to assess the impact
of the medical innovations associated with the IET over the second half of the 20th
century before the start of the global HIV/AIDS epidemic, as in Acemoglu and Johnson
(2007), Cervellati and Sunde (2011), and Hansen (2013). As we are interested in the
di¤erential impact that the new medical technologies had on the outcomes of males and
females, our data set includes for each country and year two observations, one for the
female population and one for the male population. This leads to a total sample size of
75  2  2 = 300 observations.
Section A of the Appendix lists the 75 countries that are included in our main sample.
They span all regions of the world with the exception of Sub-Saharan Africa for which
reliable data on life expectancy and mortality rates only start in 1950. In this section we
briey describe the key variables of interest, namely years of schooling, life expectancy
and mortality rates. Further information on the data sources for these variables as well
as for all additional data that we employ in our analysis can be found in Section B of the
Appendix.
To measure educational attainment, we use the gender- and cohort-specic average
years of schooling data provided by Barro and Lee (2013). Following the approach of
Hansen (2013), we focus on the cohort of individuals that was between 5 and 9 years old
in the two respective time periods (1940, 1980) and measure their educational attainment
as observed in the Barro and Lee (2013) data 10 years later (1950, 1990).7 These are
the cohorts of boys and girls that entered the formal schooling system between 1937 and
1941, and between 1977 and 1981, respectively. By comparing them we can assess how
levels of educational attainment around the globe were a¤ected by the life expectancy
improvements associated with the IET.
Data on life expectancy at birth in 1940 are drawn mainly from the various editions of
the UN Demographic Yearbook, supplemented with additional data for selected countries
as explained in Section B of the Appendix. The respective information for 1980 is obtained
from the electronic version of World Population Prospects of the UN Population Division.
We furthermore collected data for life expectancy at higher ages. The sources for these
data are the same as for life expectancy at birth, namely UN Demographic Yearbooks
for 1940 and World Population Prospects for 1980. In Section B of the Appendix we also
6In our robustness analyses we also consider alternative setups where the two time periods correspond
to di¤erent years.
7As part of our robustness analysis we explore both the measurement of educational attainment at
higher ages and the impact of life expectancy on primary, secondary and tertiary education.
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explain how we deal with missing data.
The information on mortality rates from infectious diseases used in our baseline analy-
sis is drawn from Acemoglu and Johnson (2007). The authors collect and report disease-
specic mortality rates for 13 infectious diseases in 1940. We classify these diseases into
two groups depending on whether the disease became preventable with vaccines during
the post-war era or not. The V-disease group of vaccine-preventable diseases includes
the following seven diseases: diphtheria, inuenza, measles, pneumonia, smallpox, tuber-
culosis, whooping cough. The remaining six diseases that fall into the NV-disease group
of non-vaccine-preventable diseases are: cholera, malaria, plague, scarlet fever, typhoid
fever, typhus. Section C of the Appendix provides detailed information on the char-
acteristics and key methods of control of each disease based on which we perform this
classication.
These mortality rates, however, are not gender-specic, but refer to the total popula-
tion of each country. We, therefore, assign in our rst-stage regression specication (2)
the same values to the male and female population in each respective country and only
allow their e¤ect on life expectancy to di¤er across genders. For a smaller sample of 22
countries, though, we obtain gender-specic mortality rates from infectious diseases in
1940 from Preston et al. (1972). These countries are listed in Section A of the Appendix.
Based on this smaller sample we provide some robustness analyses in Section 6.1.
For the year 1980, on the other hand, we do not collect actual mortality rates. This
is because our mortality variable should not reect the actual country-specic mortality
environment in that period, but the conditions at the global health frontier. By capturing
the predicted mortality changes for each country before and after the IET, our mortality
variable can function as an instrument for the actual changes in life expectancy between
1940 and 1980.
For our baseline analysis we follow Acemoglu and Johnson (2007) and take the frontier
mortality rates in 1980 to be zero for all infectious diseases. As an alternative to this
approach, we can assume that all countries experience the same proportionate reductions
in mortality between 1940 and 1980, rather than reaching the same level in 1980. In this
case, the predicted mortality rate for each disease in 1980 is taken to be equal to the
country-specic rate in 1940 scaled down by the average rate at which mortality fell for
that disease at the global level. As a second alternative, we assume that the predicted
mortality rates for all countries in 1980 equal the values observed in the United States in
that year, which are close to but not equal to zero.
Table 2 shows the descriptive statistics for all key variables. For average years of
schooling and life expectancy at birth the statistics are reported separately for males and
females. As these gures clearly indicate, both schooling and life expectancy increased
substantially between 1940 and 1980 and these increases were larger for females than for
males. The exact nature of this relationship is what we investigate in the next section.
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[Insert Table 2 around here]
5 Baseline Regression Results
Table 3 presents the results from the estimation of our baseline specication with 2SLS.
Panel A shows the results of the rst-stage estimation based on di¤erent variants of
equation (2), while Panel B shows the results of the corresponding second-stage estimation
of equation (1). Standard errors, reported in brackets, are clustered at the gender-country
level in line with the employed xed-e¤ects.
In column 1 we present a simple variant of the rst-stage estimation where we omit the
interaction term with the female dummy and we do not separate the mortality rates into
di¤erent disease groups. Instead we look at the overall e¤ect of the predicted mortality
reductions from the 13 infectious diseases on life expectancy at birth. As the estimated
coe¢ cient indicates, the improvements in the mortality environment that took place
between 1940 and 1980 had a large and statistically signicant e¤ect on life expectancy.
On average the estimates imply an increase in life expectancy at birth by 7 years, which
is similar to the magnitudes reported by Acemoglu and Johnson (2007).
[Insert Table 3 around here]
In column 2 we estimate separately the e¤ect of the predicted mortality reductions
for males and females by including in the specication the interaction term between
the female dummy and the predicted mortality rates. The estimated coe¢ cient for the
interaction term is negative and statistically signicant at the 1% level, indicating that
female life expectancy, on average, rose faster between 1940 and 1980 than male life
expectancy in response to the same predicted improvements in the mortality environment.
Specically, the estimated coe¢ cients of  12:9 and  4:9 imply that male life expectancy
increased on average by 5.6 years in response to changes in predicted mortality and female
life expectancy increased by 7.8 years. This corresponds to 33% and 39% of the actual
life expectancy increases for males and females respectively observed over this period in
our sample of countries. The relatively larger e¤ect on female life expectancy does not
imply that female life expectancy increases more in response to the same reduction in
actual mortality. By construction life expectancy at birth reects the overall mortality
environment at a specic point in time and its calculation is gender-invariant. Instead,
we should interpret the absolutely larger coe¢ cient for females as reecting that the
actual mortality reductions experienced by females in response to the post-1940 medical
innovations were larger than those for males. These e¤ectively larger mortality reductions
in turn gave rise to relatively larger increases in life expectancy.
In column 3 we estimate again the di¤erential e¤ects of the predicted mortality reduc-
tions for males and females, but distinguishing this time between mortality from vaccine-
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preventable diseases (V-disease group) and from non-vaccine-preventable diseases (NV-
disease group). As we can see from the estimated coe¢ cients, the predicted reductions
in mortality rates from both groups of diseases were associated with signicant increases
in life expectancy. Moreover, as the interaction term with the female dummy reveals,
the reduction in predicted mortality from vaccine-preventable diseases led to statistically
signicantly larger increases in female life expectancy than in male life expectancy. In
contrast, the corresponding coe¢ cient on the interaction e¤ect with predicted mortality
from non-vaccine-preventable diseases is statistically insignicant. This result is, thus, in
line with the ndings of the medical studies summarized in Section 2 which nd vaccine
e¢ cacy to be higher among females.
The estimation results of column 3 imply that between 1940 and 1980 female life
expectancy increased more than male life expectancy in countries where the mortality
improvements were largely the result of vaccination campaigns. In countries where these
improvements were driven by the introduction of new drugs or other health interventions,
however, this does not appear to be the case. Comparing the magnitudes of these di¤er-
ences we see that, as a consequence of the mortality reductions from vaccine-preventable
diseases, male life expectancy rose on average by 4.2 years and female life expectancy
by 6 years. This means that the e¤ect for females is 43% higher than that for males.
Looking at the corresponding magnitudes for non-vaccine-preventable diseases instead,
we nd that the mortality reductions led to increases in life expectancy by on average
1.2 years for males and 1.55 years for females, with the di¤erence between the two being
statistically insignicant.8
In columns 4 and 5 we present the estimation results for the same regression spec-
ication but where the predicted mortality rates in 1980 are not assumed to be zero,
but adjusted as described in Section 4. Specically, in the estimation in column 4 we
assume that mortality rates fell proportionately in line with the evolution of the global
average, while in the estimation in column 5 we assume that the mortality rates fell to
the levels observed in the United States in 1980. In both cases the estimation results are
very similar to the baseline result reported in column 3, conrming the pattern of a rela-
tively stronger response of female life expectancy to changes in predicted mortality from
vaccine-preventable diseases, but an insignicant gender-specic response to changes in
predicted mortality from non-vaccine preventable diseases.
Turning to Panel B of Table 3, we can see the second-stage estimates of the 2SLS
estimation that correspond to the rst-stage estimations described above. The results in
all cases are remarkably consistent.9 Irrespective of the exact set-up in the rst stage, the
8While the point estimate of  5:6 on the interaction term appears large, the actual magnitude of the
e¤ect is quantitatively not important as the variation in mortality rates for the NV-disease group in our
sample is not very high.
9Also the reported F-statistics for the signicance of the instruments in the rst-stage yield in all
cases values safely above the critical threshold of 10 suggested by Staiger and Stock (1997).
14
second-stage estimates suggest that improvements in life expectancy between 1940 and
1980 led to a signicant increases in average years of schooling. Since the underlying life
expectancy gains were higher for females than for males, this translates into relatively
higher increases in educational attainment of females compared to males.10 The coe¢ -
cient estimate of 0.115 in column (2) in combination with the predicted changes in life
expectancy from the rst stage regression imply an increase in schooling of on average
0.65 years for males and 0.9 years for females.11 The resulting reduction of 0.25 years in
the education gender gap can account for 80% of the actually observed reduction in the
education gender gap over the sample period.
Comparing these estimates with previous work in the literature is also reassuring. Our
second-stage coe¢ cient estimate suggests that one extra year of life should lead to an
increase in schooling by 0.115 years. This is similar to the e¤ects found by Jayachandran
and Lleras-Muney (2009) who report e¤ect sizes between 0.11 and 0.15 years of schooling
for each addition year of life. Alternatively, we can look at the implied elasticities of
changes in educational attainment to changes in life expectancy. These elasticities are
found to be between 0.6 and 1 by Jayachandran and Lleras-Muney (2009) based on data
from Sri Lanka, and between 0.8 and 1.3 by Oster, Shoulson and Dorsey (2013) based on
data from the United States. In our setup, given the initial levels of life expectancy and
schooling, mortality reductions associated with the IET increased life expectancy by 16%
for women and 12% for men. This in turn resulted in a 21% increase in average years
of schooling for females and 14% for males, thus implying an elasticity of 1.18 for males
and 1.34 for females.
6 Robustness Checks
Having demonstrated the quantitative importance and the statistical signicance of the
link between the di¤erential improvements in life expectancy across genders and the clos-
ing of the education gender gap in our baseline regressions, we proceed in this section to
establish its robustness. For this purpose, we rst explore the robustness of our rst-stage
estimation by looking at mortality from di¤erent sub-groups of infectious diseases and by
employing gender-specic mortality rates. We then proceed to assess the robustness of
our second-stage estimation by adjusting our country sample, considering life expectancy
10While not reported here, we also tested for whether the same improvements in life expectancy had
di¤erential e¤ects on educational attainment of males and females. In none of the cases, though, we
found any evidence for this. This suggests that the observed di¤erential increases in years of schooling
of females and males are solely due to di¤erential improvements in life expectancy and not to di¤erential
responses in schooling to given increases in life expectancy.
11We should note here that, compared to the actual increases in schooling of 3.15 years for males
and 3.5 years for females that we observe in our sample, the increases predicted by our estimation may
appear small. Yet, this is natural and should be expected given the presence of several other factor that
contributed to increases in schooling between 1940 and 1980.
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at di¤erent ages and using alternative measures of educational attainment. Finally, we
also compare the relative importance of our explanation for the closing of the education
gender gap with alternative ones proposed in the literature.
6.1 Robustness of First-Stage Estimation
If increases in life expectancy resulting from the introduction of vaccines are stronger
for females than for males, as established in our rst-stage estimation, then this pattern
should be observable also for individual diseases as well as sub-groups of diseases. With
that in mind in columns 1, 2, and 3 of Table 4 we repeat our rst-stage estimation
focusing on changes in mortality rates from the three most important infectious diseases
of that time: malaria, pneumonia, and tuberculosis. Doing so is instructive as these three
diseases together account for 87% of mortality from the 13 infectious diseases in 1940.
In each of the three columns, we report the e¤ect of the predicted changes in mortality
from one of the three diseases, as indicated in the top part of the table, while controlling
at the same time for the predicted changes in mortality rates from the remaining twelve
diseases with the Residual Mortality variable.
[Insert Table 4 around here]
Comparing the estimation results across the three columns, we nd that the interac-
tion term between the female dummy and the predicted changes in mortality is statis-
tically insignicant for the case of malaria, but negative and statistically signicant for
the case of pneumonia and tuberculosis. These results are in line with the expectation
that the relatively larger gains in female life expectancy over this period were driven by
a stronger immune response of females to vaccination. As we explain in greater detail in
Section C of the Appendix, both pneumonia and tuberculosis are diseases which after
1940 largely became preventable with vaccines. Malaria, on the other hand, was primar-
ily controlled by newly developed insecticides, such as DDT, and to this date no e¤ective
vaccine exists.
Given the importance of these three diseases over our sample period, an important
test is to ensure that our results are not only driven by a di¤erential response of females to
specic treatment methods for malaria, pneumonia and tuberculosis. For this purpose in
column 4 we focus on the remaining ten diseases, splitting them once again into a group
of diseases that became vaccine-preventable after 1940 and a group of diseases that did
not. In this setup we also control at the same time for predicted mortality from the three
excluded diseases in the Residual Mortality variable. As the results demonstrate, we see
again di¤erential changes in female life expectancy resulting from predicted reductions in
mortality from diseases of the V-group, even with pneumonia and tuberculosis excluded,
but not for diseases of the NV-group.
16
A related concern regarding our rst-stage estimation is that the observed di¤eren-
tial life expectancy gains for females and males may be due to variation in the causative
agent behind the diseases rather than the role of vaccination and other methods of disease
control. While the medical literature has not documented any di¤erences in the immune
response of females and males across di¤erent types of causative agents, we nevertheless
test for this by separating the 13 diseases with respect to their causative agent (bacteria,
viruses, parasites) as well as their main method of control. As all viral diseases in our
data set (inuenza, measles, smallpox) are vaccine-preventable and malaria is the only
parasitic disease, for this robustness check we focus on just bacterial diseases. In column
5 we separate the nine bacterial diseases in our data set into vaccine- and non-vaccine-
preventable ones and interact the predicted mortality rates from these two groups of
diseases with the female dummy. In this setup again we control for the predicted mor-
tality rates from the remaining four non-bacterial diseases with the Residual Mortality
variable. Once again we nd evidence that predicted mortality reductions resulting from
the introduction of vaccines were associated with larger gains in life expectancy for fe-
males than for males, while the responses in life expectancy to other methods of disease
control were uniform across genders. Thus, we can safely conclude that the patterns that
we observe are not driven by the causative agent behind the di¤erent infectious diseases.
A nal concern regarding our rst-stage estimation may be the fact that the employed
predicted mortality rates are not gender-specic. While disease-specic mortality rates
in 1940 are not available by gender for all 75 countries in our main sample, as we already
mentioned in Section 4, such information is available for a small sample of 22 countries.
Based on the data reported by Preston et al. (1972) we construct gender-specic mortality
rates in 1940 for two groups of infectious diseases: a group of vaccine-preventable diseases
that includes inuenza, pneumonia and tuberculosis and a residual group containing all
other infectious diseases. The robustness of our main nding using these data is explored
in columns 5 and 6. In both cases we assume, in line with our baseline estimation, that
the mortality rates from all diseases would fall to zero by 1980.
In the estimation in column 5 we employ the data for this small sample of countries,
but ignore gender di¤erences in mortality rates by assigning the country-wide mortality
rates to both males and females, just like in our baseline specication. The estimation in
column 6 employs the actual gender-specic mortality rates for males and females. The
estimation results in both cases are similar.12 Controlling for the predicted reductions
in mortality from the diseases of the residual group, the predicted declines in mortality
from inuenza, pneumonia and tuberculosis, which became preventable with vaccines,
had a signicantly larger e¤ect on female life expectancy. The corresponding absolute
12Due to the small sample size, in this setup we are forced to reduce the number of included xed
e¤ects by employing separate xed e¤ects for gender and country rather than one for each gender-country
pair.
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magnitudes of the e¤ects are slightly higher when we employ the gender-specic mortality
rates, but are qualitatively similar. Hence, these results suggest that the fact that we
cannot employ gender-specic mortality rates in our main specication, if anything, will
lead to an underestimation of the di¤erential increases in female life expectancy that
resulted from the IET.
6.2 Robustness to Sample Composition and Life Expectancy
Measurement
Having shown that the rst-stage estimation results do not hinge on the exact way in
which we specify our predicted mortality instrument, we proceed to assess the robust-
ness of our overall 2SLS estimation. A crucial assumption behind our estimation is that
the mortality instrument can be reasonably excluded from our second-stage specication.
Practically this means that the predicted changes in mortality rates from infectious dis-
eases that occurred between 1940 and 1980 as a result of the IET were exogenous to
the potential of men and women in our sample of countries to attain a given level of
education. While this assumption seems plausible for most countries in our sample, it
may not entirely hold for the countries that were actively involved in the development of
the key medical and chemical innovations that led to the IET. This group of countries in-
cludes France, Germany, Switzerland, the United Kingdom and the United States. With
that in mind, in column 1 of Table 5, we omit these countries from the sample. As we
can see, this modication of our country sample does not a¤ect our main ndings. The
estimated coe¢ cients for all variables are very similar to those reported in Table 3 and
we continue to observe a relatively stronger e¤ect of the predicted mortality reductions
from vaccine-preventable diseases on the life expectancy of females.
[Insert Table 5 around here]
Another concern regarding our estimates has to do with the quality of the data. As
for some of the 75 countries in our sample the main data may not be very reliable, in
columns 2 to 4 of Table 5 we omit one by one certain groups of countries for which
data quality may be questionable. Specically, in column 2 we omit African and Middle
Eastern countries, in column 3 small Latin American and Caribbean countries, and in
column 4 Eastern European countries. In all cases we can see from the resulting estimates
that omitting these groups of countries does not alter our ndings in any signicant way,
neither in the rst stage nor in the second stage.
Up to this point our analysis has focused solely on the link between life expectancy
at birth and educational attainment. We do so, as life expectancy at birth is the most
common indicator of the overall mortality environment in a given country. Yet, mortality
improvements may raise educational attainment in di¤erent ways depending on the exact
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age at which these improvements are realized. With that in mind it is instructive to
consider the relative role played by mortality improvements in childhood versus adult-
hood. Hence, in columns 5 and 6 of Table 5, we replace life expectancy at birth with life
expectancy at the ages of 5 and 20 respectively. Doing so leads to a sizeable decrease
in our sample size as these alternative measures are not available for all countries in our
sample. As the estimates reveal, though, this does not alter the qualitative nature of our
previous ndings.
In particular, we should note here that while the second stage results in Panel B
suggest that improvements in life expectancy at higher ages have a larger e¤ect on edu-
cational attainment, this is not actually the case. The higher estimated coe¢ cients are
a consequence of the fact that the changes in life expectancy at age 5 or 20 were smaller
than those at birth. Expressed in terms of standard deviation changes, the magnitudes
of the e¤ects are very similar to that in the baseline regression with a one standard de-
viation increase in predicted life expectancy raising educational attainment between 0.24
and 0.26 standard deviations.13
6.3 Robustness to Alternative Measures of Educational Attain-
ment and Time Trends
As a further check on the robustness of our estimation results, it is instructive to inves-
tigate the relationship between life expectancy improvements and alternative measures
of educational attainment. This is what we focus on in Table 6. Specically, in column
1 we begin by looking at how the improvements in life expectancy between 1940 and
1980 a¤ected the educational attainment of the cohorts of males and females who started
school 5 years later, namely in 1945 and 1985. These are cohorts that started their for-
mal schooling after World War II was over and, hence, their schooling should not have
been a¤ected by disruptions caused by the war. As the estimated coe¢ cient in Panel B
reveals, the e¤ect of life expectancy on schooling for these two cohorts is very similar to
the baseline case. Thus, our nding does not seem to hinge on wartime disruptions in
the education systems that occurred in the countries involved in World War II.
[Insert Table 6 around here]
Having established this result, in columns 2 to 4 we proceed to assess whether the
link between life expectancy at birth and educational attainment operates more at the
primary schooling level or at the high level. For this purpose we use as our dependent
variable in the second-stage estimation, instead of average years of schooling, the share of
13Repeating our baseline 2SLS estimation with life expectancy at birth but restricting the sample to
those countries for which life expectancy data at age 5 or 20 are available produces almost the same point
estimates as in Table 3. Thus, the di¤erence in the estimated coe¢ cients in columns 5 and 6 compared
to Table 3 are not the result of changes in the sample composition.
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the respective cohort in the population that has completed primary education in column
2, secondary education in column 3, and tertiary education in column 4. While the point
estimates are not directly comparable between these three cases and our baseline setup
where we focus on average years of schooling, qualitatively the results are in line with
the previous ones showing a signicant positive e¤ect of life expectancy improvements on
educational attainment at all levels of education. Specically, the estimates imply that
the improvements in life expectancy observed between 1940 and 1980 led on average to a
19 percentage point increase in the primary school completion rates of males and to a 21
percentage point increase in that of females. For secondary education, the corresponding
increases in the completion rates for males and females are 2.3 and 1.8 percentage points
respectively, while at the tertiary level they are 0.7 and 0.3 percentage points. These
gures suggest that the global health improvements over the post-war period had the
largest impact on primary education. This is not surprising given that many of the
new treatment methods for infectious diseases beneted primarily young children who
may have otherwise been forced to drop out of school at a young age or never started
school to begin with.14 Given that among cohorts who started school around 1940 less
than 15% of the population completed secondary education and less than 5% completed
tertiary schooling, the relatively larger increases for females in terms of primary schooling
completion rates over the subsequent 40 years appear as the main driver behind the overall
observed fall in the overall education gender gap.
An important concern regarding all the results presented so far is that they could
be driven by pre-existing trends in the schooling data that happen to coincide with
time trends in the life expectancy data but may be unrelated to the life expectancy
improvements triggered by the IET. To check that this is not case, in column 5 of Table 6
we lag our average years of schooling data by 40 years and include it as a control variable
in both our rst- and second-stage specication. In both cases we nd lagged schooling
to be statistically insignicant and to not a¤ect our main coe¢ cients of interest. As a
further test for pre-existing trends in the data, in column 6 we conduct a falsication
test by replacing our baseline schooling variable with its 40th-year lag. If post-war life
expectancy improvements can predict the rise in schooling observed between 1900 and
1940, this would indicate that our previously estimated relationship may be spurious and
that the post-1940 increases in educational attainment would have occurred even in the
absence of the IET. Reassuringly, though, we nd the relationship between the two to
be weak and statistically not di¤erent from zero. This should makes us condent that
pre-existing trends in the schooling data are not driving the results.
14This nding is very much in line with evidence summarized in Almond and Currie (2011) regarding
the large e¤ects of disease exposure in early childhood on schooling outcomes.
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6.4 Robustness to Alternative Explanations for the Rise in Fe-
male Schooling
The existing literature on the education gender gap, summarized in the introduction,
has already highlighted several factors that may account for the relative rise in female
educational attainment over the past decades. As the relative importance of these factors
has not been analyzed before in a cross-country setting, it is instructive to consider them
and compare them with the improvements in life expectancy that our analysis emphasizes.
This comparison is o¤ered in Table 7 where we include in our baseline specication various
additional control variables that reect these alternative explanations for the rise in female
schooling. Further details on the construction of these variables are provided in Section
B of the Appendix.15
[Insert Table 7 around here]
In column 1, we start by controlling for each countrys level of GDP per capita in the
respective year in both the rst- and second-stage of our estimation. Economic develop-
ment is bound to have a positive e¤ect on both life expectancy and schooling levels of
males and of females, as it helps in correcting pre-existing gender imbalances (Galor and
Weil, 1996; Doepke and Tertilt, 2009).16 As the estimation results reveal, controlling for
the level of economic development does not alter our ndings. The coe¢ cient on GDP per
capita is not statistically di¤erent from zero in the rst-stage estimation. Moreover, its
inclusion does not change the previously established pattern in the rst-stage estimation
with predicted mortality reductions from vaccine-preventable infectious diseases leading
to relatively stronger increases in female life expectancy. In the second-stage estimation,
GDP per capita is positively associated with average years of schooling. Yet, its inclu-
sion appears to increase the quantitative importance of the e¤ect of life expectancy on
educational attainment.
In column 2, we consider the role of voting rights for women, which many authors in
the literature have emphasized.17 To control for this channel we include in our specica-
tion, a dummy variable reecting whether women had the right to vote in the respective
sample year. As we can see in Panel A, this variable is positively associated with life
expectancy but its inclusion does not a¤ect the link between mortality improvements
associated with the IET and increases in life expectancy. The variable is also positively
correlated with average years of schooling, as we can see in Panel B. Yet, the estimated
15As the required data for the construction of some of these additional control variables are available
only for a small set countries, the sample size in these regressions varies and occasionally we are forced
to reduce the number of included xed e¤ects. The exact nature of xed e¤ects employed in each
specication is indicated in the second row from the bottom in Table 7.
16See also Duo (2012) for a detailed survey of the literature.
17See Doepke, Tertilt and Voena (2012) for a summary of the literature.
21
coe¢ cient is in this case statistically insignicant and its inclusion does not overturn the
positive e¤ect of life expectancy on educational attainment.
In column 3, we investigate the role played by changes in labor force participation of
males and females over our sample period. This is motivated by the argument made by
Goldin (2006) that improved labor market conditions for females increased their returns
to schooling compared to men. While this mechanism may have been important in the
case of some developed countries, such as the United States, in the context of our broad
country-sample it does not appear to be quantitatively important. Moreover, controlling
for it does not alter the patterns observed in our baseline regressions.18
In columns 4 and 5 we explore the role that characteristics of the marriage mar-
ket played in the educational choices made by males and females. This relates to the
arguments regarding the importance of education in the marriage market presented by
Chiappori et al. (2009) in the case of developed countries as well as Ashraf et al. (2016) in
the case of developing countries. To capture this idea, we introduce two control variables
that reect the conditions in the marriage market and the relative status of women in a
marriage. The rst one is the average age at marriage of the male and female population.
The second one is the average age di¤erence at marriage between brides and grooms,
which captures the relative power of women in the household, as discussed by de Moor
and van Zanden (2009). Controlling for these two variables does not change our main
ndings regarding the link between life expectancy and schooling. The average age at
marriage is positive related to life expectancy, as we see in column 4, but beyond this the
inclusion of this variable has no further implications.19
In column 6 we assess the importance of changes in fertility behavior over our sample
period. Theories about the demographic transition clearly link fertility rates with life
expectancy and educational attainment.20 With that in mind, we add fertility rates as a
control in our specication. As the regression results indicate, higher fertility rates are
associated with lower levels of life expectancy. Controlling for this e¤ect, however, does
not a¤ect the main regression coe¢ cients, neither in the rst stage nor in the second
stage.
While exploring alternative mechanisms that may account for the empirical patterns
reected in our regressions, it is important to consider also other factors that may have
inuenced male and female mortality in our sample countries but are unrelated to infec-
18While the size of the estimated coe¢ cients in the rst and second stage di¤er from those shown in
Table 3, this is not a consequence of controlling for labor force participation, but solely due to the change
in sample size.
19Similar to the case of column 3, the change in the point estimates of the regression coe¢ cients in
columns 4 and 5 is largely driven by the changing sample size.
20As parents face a trade-o¤ between the quantity and the quality of their children, they are more
likely to invest in their education in a low fertility environment. At the same time, a lower level of
fertility also implies that mothers have more opportunities to participate in the labor market, which in
turn would increase the returns to their own human capital investment. See Galor (2011) for an overview
of the theories regarding the demographic transition.
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tious diseases. Given our time period of interest, factors that are particularly important
are improvements in maternal mortality, highlighted by Albanesi and Olivetti (2016),
as well as changes in mortality from cancer and cardiovascular diseases, emphasized by
Deaton (2003). In columns 7 and 8, we control for these factors using available data on
maternal mortality rates and mortality from cancer and cardiovascular diseases, which
exhibit a strong male bias. Controlling for maternal mortality leaves our main ndings
intact. Controlling for mortality rates from cancer and cardiovascular diseases changes
quantitatively the magnitudes of our estimated e¤ects, but this is due to the substantial
reduction in the sample size, not to the inclusion of the control variables. Qualitatively,
we continue to observe the previously established pattern that improvements in the mor-
tality environment associated with the IET had larger e¤ects on the life expectancy of
females than of males. We also continue to nd positive e¤ects of life expectancy on
educational attainment in the second-stage regression.
Beyond the aforementioned factors, of course, there are also other factors that may
have played a role in the relative rise of female educational attainment and the closing of
the education gender gap, such as the introduction of the birth control pill, stressed by
Goldin and Katz (2002), or the decline in the price of household appliances, highlighted
by Greenwood et al. (2016). In the context of our analysis, though, the e¤ect of these
factors are largely captured by the year xed e¤ects, as the di¤usion across most countries
largely took place between 1940 and 1980.21 Gender norms as well as other cultural
and institutional attributes of countries are also expected to inuence the health and
educational outcomes of males and females. Yet, as these factors have been shown to be
highly persistent (Alesina et al., 2013; Hansen et al., 2015), they are largely captured by
our gender-country xed e¤ects.
7 Implications for Economic Development
So far we have established with our regression analysis that: (a) the global reductions
in mortality from infectious diseases associated with the IET led to substantial improve-
ments in life expectancy, (b) these improvements led to sizeable increases in educational
attainment, and (c) females experienced larger improvements in life expectancy and as a
consequence their schooling levels rose more than those of men. In this section we explore
the broader implications that these mortality reductions had for economic development.
An extensive body of literature, summarized by Deaton (2003) and Weil (2014), has
highlighted various channels through which improvements in health a¤ect the process
of economic development and vice versa. Yet, in the context of the IET Acemoglu and
21The birth control pill, for example, is a case in point here. It was rst approved by the FDA in 1957
and by 1990 the year in which we observe the educational attainment of our 1980 school cohort, it was
available for use in all 75 of the countries in our sample apart from Myanmar (Finlay et al., 2012).
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Johnson (2007) have already documented that the large improvements in life expectancy
did not materialize in higher levels of GDP per capita. As these authors demonstrate,
this is because the increases in aggregate GDP were o¤set by increases in the size of
the population triggered by the lower mortality rates. Cervellati and Sunde (2011) have
further explored this pattern and have shown that the e¤ects of the life expectancy
improvements on GDP per capita were not uniform across countries. In countries that had
already experienced the demographic transition by 1940 and where fertility was already
low, the IET led to increases GDP per capita, as the e¤ect on the numerator of GDP
per capita was larger than that on the denominator. On the other hand, in countries
that had not yet experienced the demographic transition the e¤ect of life expectancy
improvements on GDP per capita was largely negative.
Given our nding of non-uniform gains in life expectancy between males and females
associated with the IET, it is instructive to assess whether the life expectancy improve-
ments of males and females had di¤erential impacts on per capita GDP. In fact, there is
already some work in the literature suggesting this possibility. The models of the demo-
graphic transition proposed by de la Croix and Vander Donckt (2010) as well as Bloom
et al. (2015) highlight how improvements in female health tend to be more conducive to
economic development compared to improvements in male health. This is because health
improvements for males and females, while they are conducive to educational attain-
ment, have di¤erential e¤ects on fertility and labor force participation. An improvement
in male health generates primarily an income e¤ect on households, which increases both
consumption and desired fertility. An improvement in female health, on the other hand,
has beyond an income e¤ect also a substitution e¤ect, which tends to lower fertility and
raise labor force participation. This is due to the fact that women naturally contribute a
larger share of their time in child-rearing activities.
To our knowledge, the existing literature has not o¤ered an empirical test for these
di¤erential e¤ects of male and female health improvements on economic development.
This is largely due to the fact that male and female life expectancy are very highly
correlated and their distinct e¤ects cannot be estimated within the same regression. Our
empirical setup, however, which links the di¤erential improvements in male and female
life expectancy to the exogenous mortality reductions from vaccine- and non-vaccine-
preventable diseases implied by the initial disease environment, allows us to indirectly test
the link between male and female life expectancy and economic development. Specically,
this can be done by estimating the following reduced-form specication:








Mdct + dc + dt + ect: (3)







Mdct correspond to the predicted mortality rates for the groups of vaccine-preventable
(V ) and non-vaccine-preventable (NV ) infectious diseases. The specication includes
country and year xed e¤ects, dc and dt; and is estimated in long-di¤erences between
1940 and 1980 using the same sample of countries as in our baseline regressions.22 Given
the results of our analysis so far and the hypothesis that female health improvements
are more conducive to economic development, we would expect the coe¢ cient bV to be
smaller than bNV as reductions in predicted mortality from vaccine-preventable infectious
diseases would lead to larger improvements in female health than reductions in predicted
mortality from non-vaccine-preventable ones.
The results of estimating equation (3) can be seen in Table 8. In column 1, we estimate
rst a simple specication in which we do not split the diseases into di¤erent groups, but
look at how the overall reductions in predicted mortality from the 13 infectious diseases
a¤ected per capita GDP levels. The estimated coe¢ cient is positive and statistically
signicant. This implies that the reductions in mortality were associated with a drop
in GDP per capita and the drop was on average larger in countries where mortality fell
more. This estimate, thus, mirrors the ndings of Acemoglu and Johnson (2007) that
global improvements in health associated with the IET did not lead to improvements in
income.
[Insert Table 8 around here]
Having shown this, in column 2 we separate the overall predicted mortality reductions
between those coming from the V and NV disease groups. As the estimation results
indicate, there is a positive association between changes in mortality and GDP per capita
for the latter group, but an insignicant association for the former group. Hence, drops
in GDP per capita were on average observed in countries where the mortality reductions
came primarily from non-vaccine-preventable diseases. In countries where the mortality
reductions came primarily from vaccine-preventable diseases, which are the countries
where on average female life expectancy rose more than male life expectancy, mortality
reductions did not have a negative e¤ect on GDP per capita.
In column 3 we explore this pattern further by separating the countries in our sam-
ple into those that had already experienced the demographic transition (DT) by 1940
and those that had not. We do so following the classication of Cervellati and Sunde
(2011).23 Starting with our simple specication of column 1 and interacting the overall
change in predicted mortality with a post-DT dummy variable, we nd that the e¤ect of
the mortality reductions on per capita GDP was di¤erent for pre- and post-transitional
22Out of the 75 countries in our main sample, we have to drop six for which GDP per capita is not
available in 1940.
23Specically, we classify countries as post-transitional if by 1940 life expectancy at birth exceeded 50
years, there was a sustained decline in fertility, or the crude birth rate had fallen below 30/1000.
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countries. While in the former group of countries mortality reductions were associated
with a fall in GDP per capita, in the latter group they contributed to a rise in per capita
GDP. This conrms the nding of Cervellati and Sunde (2011) that countries which had
already undergone the demographic transition by 1940 experienced a rise in income levels
as a result of the post-1940 improvements in the health environment.
Column 4 combines the estimation setups of columns 2 and 3 by interacting the
post-DT dummy with the predicted mortality reductions coming from the V and NV
disease groups. As the estimation results indicate, there is a negative and statisti-
cally signicant association between changes in GDP per capita and changes in mor-
tality in post-transitional countries, but this relationship only applies to mortality from
vaccine-preventable diseases. For non-vaccine-preventable diseases, the association be-
tween changes in GDP per capita and changes in mortality is positive and statistically
signicant in both pre- and post-transitional countries. Noting that the countries where
the mortality reductions were primarily driven by vaccination were also the ones where on
average females gained more than males in terms of life expectancy, these results suggest
the existence of a positive association between female health improvements and economic
development once a country has achieved the demographic transition. On the other hand,
no such positive association can be observed for male health improvements.
8 Conclusion
In this paper, we establish a connection between two important global developments that
took place over the second half of the 20th century: the unprecedented improvements
in life expectancy and the sharp rise in the relative educational attainment of women.
In particular, we argue that these changes were to a large extent driven by the spread
of western medical technologies around the globe. Following the coordinated e¤orts of
the United Nations and the World Health Organization after World War II, both rich
and poor countries witnessed large reductions in mortality rates from previously highly
infectious diseases. While the e¤ect that these developments had on life expectancy across
countries is well documented, the di¤erential nature of the life expectancy gains for males
and females and their consequences for the closing of the education gender gap are a novel
contribution of our analysis.
To establish this connection econometrically and determine the direction of causality,
we rely on the exogenous nature of the mortality reductions experienced by individual
countries. This exogeneity assumption is justied by the fact that the mortality reduc-
tions were a product of medical research in a small group of developed countries. We,
furthermore, exploit biological di¤erences in the immune response of males and females
to vaccination in order to establish the di¤erential e¤ect of the implied mortality reduc-
tions on life expectancy across genders. As has been recently documented in the medical
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literature, females are better protected from a disease after vaccination since vaccine ef-
cacy is higher for them compared to males. Hence, the improvements in the mortality
environment that were achieved after World War II thanks to the introduction of new
and improved vaccines were bound to raise the life expectancy of females more than that
of males.
Following this empirical strategy, we document that in countries were female life
expectancy rose faster, as a result of the pattern of mortality reductions, there was also
a more rapid increase in female educational attainment. Moreover, we show that this
mechanism can explain a substantial share of the decline in the education gender gap
observed over this period. In additions to that, we present evidence that the countries
experiencing these relatively larger increases in female life expectancy and education also
saw increases in terms of their GDP per capita levels. Thus, the relatively larger health
improvements for females appear to have had broader macroeconomic e¤ects beyond
raising female educational attainment.
Overall our ndings suggest that public health policies, particularly those targeted at
the female population, can be an important mechanism to empower women and promote
gender equality. As poor health outcomes early in life may lead women to underperfom
in school and in the labor market later in life, policies targeted at improving these health
outcomes for females can yield sizeable economic and social benets. In this respect
our analysis resonates well with an extensive literature that has documented a strong
connection between the health status of children and their subsequent performance in
school and in the labor market (Almond and Currie, 2011). The results of our analysis
also support the view that female empowerment can have broader benets in terms of
economic development (Duo, 2012). At the same time, though, our ndings suggest
that these benets will take time before they will materialize and they may require large-
scale policy commitments, such as those made by the UN and the WHO in the 1940s to
eradicate infectious diseases.
References
Acemoglu, Daron, and Simon Johnson. 2007. Disease and Development: The E¤ect
of Life Expectancy on Economic Growth.Journal of Political Economy, 115(6): 925
985.
Albanesi, Stefania, and Claudia Olivetti. 2016. Gender Roles and Medical
Progress.Journal of Political Economy, 124(3): 650695.
Alesina, Alberto, Paola Giuliano, and Nathan Nunn. 2013. On the Origins of
Gender Roles: Women and the Plough.Quarterly Journal of Economics, 128(2): 469
530.
27
Almond, Douglas, and Janet Currie. 2011. Human Capital Development before
Age Five. In Handbook of Labor Economics. Vol. 4B, , ed. David Card and Orley
Ashenfelter, Chapter 15, 13151486. Amsterdam:Elsevier.
Ashraf, Nava, Natalie Bau, Nathan Nunn, and Alessandra Voena. 2016. Bride
Price and Female Education.NBER Working Paper No. 22417.
Baghdadi, J.E., M. Orlova, A. Alter, B. Ranque, M. Chentou, F. Lazrak, ...,
and L. Abel. 2006. An Autosomal Dominant Major Gene Confers Predisposition to
Pulmonary Tuberculosis in Adults.Journal of Experimental Medicine, 203(7): 1679
1684.
Banerjee, Abhijit, Esther Duo, Rachel Glennerster, and Dhruva Kothari.
2010. Improving Immunisation Coverage in Rural India: Clustered Randomised Con-
trolled Evaluation of Immunisation Campaigns with and without Incentives.British
Medical Journal, 340(7759): 1291.
Barro, Robert J., and Jong Wha Lee. 2013. A New Data Set of Educational
Attainment in the World, 1950-2010.Journal of Development Economics, 104: 184
198.
Beaman, Lori, Esther Duo, Rohini Pande, and Petia Topolova. 2012. Fe-
male Leadership Raises Aspirations and Educational Attainment for Girls: A Policy
Experiment in India.Science, 335(6068): 582586.
Becker, Gary S., Tomas J. Philipson, and Rodrigo R. Soares. 2005. The Quan-
tity and Quality of Life and the Evolution of World Inequality.American Economic
Review, 95(1): 277291.
Ben-Porath, Yoram. 1967. The Production of Human Capital in the Life Cycle of
Earnings.Journal of Political Economy, 75(4): 352365.
Bernin, H., and H. Lotter. 2014. Sex Bias in the Outcome of Human Tropical
Infectious Diseases: Inuence of Steroid Hormones. Journal of Infectious Diseases,
209(Suppl 3): S107S113.
Bleakley, Hoyt. 2007. Disease and Development: Evidence from Hookworm Eradica-
tion in the American South.Quarterly Journal of Economics, 122(1): 73117.
Bloom, David.E., Michael Kuhn, and Klaus Prettner. 2015. The Contribution
of Female Health to Economic Development.NBER Working Paper No. 21411.
Boucekkine, Raouf, David de la Croix, and Omar Licandro. 2002. Vintage
Human Capital, Demographic Trends, and Endogenous Growth.Journal of Economic
Theory, 104: 340375.
Cernetich, A., L.S. Garver, and A.E. Jedlicka. 2006. Involvement of Gonadal
Steroids and Gamma Interferon in Sex Di¤erences in Response to Bloodstage Malaria
Infection.Infection and Immunity, 74(3): 190203.
Cervellati, Matteo, and Uwe Sunde. 2005. Human Capital Formation, Life Ex-
pectancy, and the Process of Development.American Economic Review, 95(5): 1653
1672.
28
Cervellati, Matteo, and Uwe Sunde. 2011. Life Expectancy and Economic Growth:
The Role of the Demographic Transition.Journal of Economic Growth, 16(2): 99133.
Cervellati, Matteo, and Uwe Sunde. 2015. The Economic and Demographic Transi-
tion, Mortality, and Comparative Development.American Economic Journal: Macro-
economics, 7(3): 189225.
Chiappori, Pierre-André, Murat Iyigun, and Yoram Weiss. 2009. Investment in
Schooling and the Marriage Market.American Economic Review, 99(5): 16891713.
Cook, F.I. 2008. Sexual Dimorphism of Humoral Immunity with Human Vaccines.
Vaccine, 26: 35513555.
Cutler, David M., Angus Deaton, and Adriana Lleras-Muney. 2006. The De-
terminants of Mortality.Journal of Economic Perspectives, 20(3): 97120.
Davila, S., M.L. Hibberd, R.H. Dass, E. Hazel, E. Wong, E. Sahiratmadja, ...,
and M. Seielstad. 2008. Genetic Association and Expression Studies Indicate a Role
of Toll-Like Receptor 8 in Pulmonary Tuberculosis.PLoS Genetics, 4(10): e1000218.
Deaton, A. 2003. Health, Inequality, and Economic Development. Journal of Eco-
nomic Literature, 41(1): 113158.
de la Croix, David, and Marie van der Donckt. 2010. Would Empowering Women
Initiate the Demographic Transition in Least-Developed Countries? Journal of Hu-
man Capital, 4(2): 85129.
de la Croix, David, and Omar Licandro. 2012. The Child is the Father of the Man:
Implications for the Demographic Transition.Economic Journal, 123(567): 236261.
de Moor, Tine, and Jan Luiten van Zanden. 2009. Girl Power: The European
Marriage Pattern and Labour Markets in the North Sea Region in the Late Medieval
and Early Modern Period.Economic History Review, 63(1): 133.
Doepke, Matthias, and Michele Tertilt. 2009. Womens Liberation: Whats in It
for Men?Quarterly Journal of Economics, 124(4): 15411591.
Doepke, Matthias, Michele Tertilt, and Alessandra Voena. 2012. The Economics
and Politics of Womens Rights.Annual Review of Economics, 4: 339372.
Duo, E. 2012. Women Empowerment and Economic Development.Journal of Eco-
nomic Literature, 50(4): 10511079.
Fernández, R. 2013. Cultural Change as Learning: The Evolution of Female Labor
Force Participation over a Century.American Economic Review, 103(1): 472500.
Fernández, Raquel, Alessandra Fogli, and Claudia Olivetti. 2004. Mothers and
Sons: Preference Formation and Female Labor Force Dynamics.Quarterly Journal of
Economics, 119(4): 12491299.
Fernández, Raquel, and Joyce Cheng Wong. 2011. The Disappearing Gender Gap:
The Impact of Divorce, Wages, and Preferences on Education Choices and Womens
Work.NBER Working Paper No. 17508.
29
Finlay, Jocelyn E., David Canning, and June Y. T. Po. 2012. Reproductive
Health Laws Around the World.PGDA Working Paper No. 96.
Fish, E.N. 2008. The X-Files in Immunity: Sex-Based Di¤erences Predispose Immune
Responses.Nature Reviews Immunology, 8(9): 737744.
Franconi, F., S. Brunelleschi, L. Steardo, and V. Cuomo. 2007. Gender Di¤er-
ences in Drug Responses.Pharmacological Research, 55(2): 8195.
Furman, D., B.P. Hejblum, N. Simon, V. Jojic, C.L. Dekker, R. Thiebaut, R.J.
Tibshirani, and M.M. Davis. 2013. Systems Analysis of Sex Di¤erences Reveals an
Immunosuppressive Role for Testosterone in the Response to Inuenza Vaccination.
Proceedings of the National Academy of Sciences, 111(2): 869874.
Galor, Oded. 2011. Unied Growth Theory. Princenton, NJ:Princeton University Press.
Galor, Oded, and David N. Weil. 1996. The Gender Gap, Fertility, and Growth.
American Economic Review, 86(3): 374387.
Gieng-Kroell, C., P. Berger, G. Lepperdinger, and B. Grubeck-Loewenstein.
2015. How Sex and Age A¤ect Immune Responses, Susceptibility to Infections, and
Response to Vaccination.Aging Cell, 14(3): 309321.
Goldin, Claudia. 1995. The U-Shaped Female Labor Force Function in Economic
Development and Economic History.In Investment in Womens Human Capital and
Economic Development. , ed. Schultz T. P., 6190. Chicago, IL:University of Chicago
Press.
Goldin, Claudia. 2006. The Quiet Revolution That Transformed Womens Employ-
ment, Education, and Family.American Economic Review, 96(2): 121.
Goldin, Claudia., and Lawrence F. Katz. 2002. The Power of the Pill: Oral Contra-
ceptives and Womens Career and Marriage Decisions.Journal of Political Economy,
110(4): 730770.
Goldin, Claudia, Lawrence F. Katz, and Ilyana Kuziemko. 2006. The Homecom-
ing of American College Women: The Reversal of the College Gender Gap.Journal
of Economic Perspectives, 20(4): 133156.
Greenwood, Jeremy, Nezih Guner, Georgi Kocharkov, and Cezar Santos. 2016.
Technology and the Changing Family: A Unied Model of Marriage, Divorce, Edu-
cational Attainment, and Married Female Labor-Force Participation.American Eco-
nomic Journal: Macroeconomics, 8(1): 141.
Grossman, C.J. 1985. Interactions Between the Gonadal Steroids and the Immune
System.Science, 227(4684): 257261.
Guerra-Silveira, F., and F. Abad-Franch. 2013. Sex Bias in Infectious Disease
Epidemiology: Patterns and Processes.PLoS ONE, 8(4): e62390.
Hamilton, J.B., and G.E. Mestler. 1969. Mortality and Survival: Comparison of
Eunuchs with Intact Men and Women in a Mentally Retarded Population.Journal of
Gerontology, 24(4): 395411.
30
Hansen, Casper W. 2013. Disease and Development: The E¤ect of Life Expectancy
on Economic Growth.Journal of Health Economics, 32(6): 11421152.
Hansen, Casper W., and Holger Strulik. 2017. Life Expectancy and Education:
Evidence from the Cardiovascular Revolution. Journal of Economic Growth, forth-
coming.
Hansen, Casper W., P.S. Jensen, and C.V. Skovsgaard. 2015. Modern Gen-
der Roles and Agricultural History: The Neolithic Inheritance.Journal of Economic
Growth, 20(4): 365404.
Jayachandran, Seema, and Andriana Lleras-Muney. 2009. Life Expectancy and
Human Capital Investements: Evidence from Maternal Mortality Declines.Quarterly
Journal of Economics, 124(1): 349397.
Kalemli-Ozcan, Sebnem. 2002. Does the Mortality Decline Promote Economic
Growth? Journal of Economic Growth, 7(4): 411439.
Klein, S.L., A. Jedlicka, and A. Pekosz. 2010. The Xs and Y of Immune Responses
to Viral Vaccines.Lancet Infectious Diseases, 10(5): 338349.
Klein, S. L, and A. Pekosz. 2014. Sex-based Biology and the Rational Design of
Inuenza Vaccination Strategies.Journal of Infectious Diseases, 209(Suppl 3): S114
S119.
Klein, S.L., I. Marriott, and E.N. Fish. 2015. Sex-based Di¤erences in Immune
Function and Responses to Vaccination.Transactions of the Royal Society of Tropical
Medicine & Hygiene, 109(1): 915.
Krucken, J., M.A. Dkhil, J.V. Braun, R.M. Schroetel, M. El-Khadragy, P.
Carmeliet, H. Mossmann, and F. Wunderlich. 2005. Testosterone Suppresses
Protective Responses of the Liver to Blood-Stage Malaria. Infection and Immunity,
73(1): 436443.
Lozano, R., M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, ...,
and C.J.L. Murray. 2012. Global and Regional Mortality from 235 Causes of Death
for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of
Disease Study 2010.Lancet, 380(9859): 20952128.
Lucas, Adrienne M. 2010. Malaria Eradication and Educational Attainment: Ev-
idence from Paraguay and Sri Lanka. American Economic Journal: Applied Eco-
nomics, 2(2): 4671.
Muenchho¤, M., and P.J.R. Gouldner. 2014. Sex Di¤erences in Pediatric Infectious
Diseases.Journal of Infectious Diseases, 209(Suppl 3): S120S126.
Neyrolles, O., and L. Quintana-Murci. 2009. Sexual Inequality in Tuberculosis.
PLoS Medicine, 6(12): 16.
Nhamoyebonde, S., and A. Leslie. 2014. Biological Di¤erences Between the Sexes
and Susceptibility to Tuberculosis.Journal of Infectious Diseases, 209(Suppl 3): S100
S106.
31
OECD. 2015. The ABC of Gender Equality in Education: Aptitude, Behavior, Con-
dence. PISA, OECD Publishing.
Oster, E., I. Shoulson, and R. Dorsey. 2013. Limited Life Expectancy, Human
Capital and Health Investements: Evidence from Huntington Disease.American Eco-
nomic Review, 103(5): 19772002.
Owens, P.F. 2002. Sex Di¤erences in Mortality Rate.Science, 297(5589): 20082009.
Poland, G.A., I. Ovsyannikova, and R.M. Jacobson. 2008. Genetic Susceptibility
to Infectious Diseases. , ed. R.A. Kaslow, J.M. McNichol and A.V.S. Hill, Chapter
Genetics and Immune Response to Vaccines. New York:Oxford University Press.
Preston, Samuel H., Nathan Keytz, and Robert Schoen. 1972. Causes of Death:
Life Tables for National Populations. New York, NY:Seminar Press.
Reijnders, Laurie S. M. 2017. Wealth, Wages and Wedlock: Explaining the College
Gender Gap Reversal.Scandinavian Journal of Economics, forthcoming.
Soares, Rodrigo R. 2005. Mortality Reductions, Educational Attainment, and Fertil-
ity Choice.American Economic Review, 95(3): 580601.
Soares, Rodrigo R. 2006. The E¤ect of Longevity on Schooling and Fertility: Evidence
from the Brazilian Demographic and Health Survey.Journal of Population Economics,
19(1): 7197.
Staiger, Douglas, and James H. Stock. 1997. Instrumental Variables Regressions
with Weak Instruments.Econometrica, 65(3): 557586.
Stanberry, L.R., S.L. Spruance, A.L. Cunnigham, D.I. Bernstein, A. Mindel,
S. Sacks, ..., and G. Dubin. 2002. Glycoprotein-D-Adjuvant Vaccine to Prevent
Genital Herpes.New England Journal of Medicine, 347(21): 16521661.
Svanberg, L. 1981. E¤ects of Estrogen Deciency in Women Castrated When Young.
Acta Obstetricia et Gynecologica Scandinavica, 106(S106): 1115.
Tsuyuguchi, K., K. Suzuki, H. Matsumoto, E. Tanaka, R. Amitani, and F.
Kuze. 2001. E¤ect of Oestrogen on Mycobacterium Avium Complex Pulmonary In-
fection in Mice.Clinical and Experimental Immunology, 123(3): 428434.
United Nations. Various Editions. Demographic Yearbook.New York, NY.
United Nations Population Division. 2017. World Population Prospects.
esa.un.org/unpd/wpp/.
Weil, David N. 2014. Health and Economic Growth. In Handbook of Economic
Growth. Vol. 2B, , ed. Philippe Aghion and Steven N. Durlauf, Chapter 3, 623682.
Amsterdam:Elsevier.
World Bank. 2012. Gender Equality and Development. World Development Report.
Wunderlich, F., W.P. Benten, and M. Lieberherr. 2002. Testosterone Signaling
in T Cells and Macrophages.Steroids, 67(6): 535538.
32
Yamamoto, Y., H. Saito, T. Setogawa, and H. Tomioka. 1991. Sex Di¤erences
in Host Resistance to Mycobacterium Marinum Infection in Mice.Infection and Im-
munity, 59(11): 40894096.
33
Figure 1: Global Evolution of the Education Gender Gap 
 
Notes: This figure depicts the global evolution of the education gender gap measured as the male-to-female ratio of average 
years of schooling. The data are from Barro and Lee (2013) and refer to the schooling levels of the cohort that was 15 to 19 years 




Figure 2: The Closing of the Education Gender Gap in Selected Countries 
 
Notes: This figure depicts the change in the education gender gap measured as the male-to-female ratio of average years of 
schooling between 1950 and 2000 in selected countries. The data are from Barro and Lee (2013) and refer to the schooling levels 





























































Table 1: Life Expectancy and Educational Attainment in Europe 
Year 
Life expectancy at birth, 
Females 
Life expectancy at birth, 
Males 
Avg. years of schooling, 
Females 
Avg. years of schooling, 
Males 
1900 49.8 46.9 5.6 5.9 
1913 55.1 52.2 5.6 6.0 
1928 59.7 56.8 6.5 7.2 
1939 63.7 59.6 7.3 8.1 
1950 69.9 65.9 9.0 9.8 
1964 74.7 69.1 11.2 11.4 
1977 77.3 70.7 12.2 12.1 
1990 79.4 72.8 12.5 12.1 
Notes: This table reports the levels of life expectancy at birth and average years of schooling of males and females in selected 
years. The average years of schooling data reflect the respective schooling levels of the cohort that was 5-9 years old in the 
respective year, measured 10 years later. The reported values are simple averages across a sample of 11 European countries 
(Belgium, Czechoslovakia, Denmark, France, Italy, Netherlands, Norway, Spain, Sweden, Switzerland, and United Kingdom.) 
for which life expectancy data go back to 1900. The life expectancy data were gathered from the Human Mortality Database and 




Table 2: Descriptive Statistics of Key Variables 
Variable Mean S.D. Min  Max 
Years of schooling, females, 1940 4.26 2.54 0.146 9.17 
Years of schooling, males, 1940 4.54 2.51 0.144 11.16 
Years of schooling, females, 1980 7.71 2.17 3.13 11.61 
Years of schooling, males, 1980 7.69 1.94 3.21 11.44 
Mortality, overall, 1940 0.436 0.274 0.033 1.126 
Mortality, vaccine group, 1940 0.363 0.241 0.03 0.909 
Mortality non-vaccine group, 1940 0.064 0.14 0 0.853 
Life expectancy at birth, females, 1940 49.61 12.17 28.44 70.72 
Life expectancy at birth, males, 1940 46.8 11.19 25.46 66.97 
Life expectancy at birth, females, 1980 69.64 7.5 51.51 79.6 
Life expectancy at birth, males, 1980 64.07 6.52 48.64 73.56 
Notes: This tables presents the descriptive statistics for the key variables in our analysis. The statistics reported refer to our main 
sample of 75 countries that we use in our baseline regression analysis. A precise definition of each variable and the exact data 
sources is provided in Section B of the Appendix. 
 
  
Table 3: Life Expectancy and Educational Attainment: Baseline 2SLS Estimates 
  (1) (2) (3) (4) (5) 
Panel A: 1st stage results Life expectancy at birth 
Mortality, overall -15.39 -12.938       
  [2.108] [2.167]     Female x Mortality, overall   -4.900         [2.154]     Mortality, V-group diseases    -11.538 -13.606 -11.211      [2.41] [2.842] [2.465] Female x Mortality, V-group diseases    -4.959 -5.847 -5.139      [2.440] [2.877] [2.648] Mortality, NV-group diseases    -18.534 -18.839 -18.120      [4.588] [4.663] [4.597] Female x Mortality, NV-group diseases    -5.618 -5.711 -6.008       [6.800] [6.911] [6.776] 
Panel B: 2nd stage results Years of schooling 
Life expectancy 0.117 0.115 0.114 0.114 0.112 
  [0.0444] [0.0426] [0.0415] [0.0415] [0.0426] 
Observations 300 300 300 300 296 
Countries 75 75 75 75 74 
1st stage F-statistic 77.35 43.94 22.64 22.64 21.48 
Notes: This table presents our baseline 2SLS estimates for the relationship between changes in life expectancy and educational 
attainment  measured in terms of average years of schooling between 1940 and 1980. Panel A shows the results of the first-stage 
estimation where life expectancy is instrumented by predicted mortality rates from different groups of infectious diseases, while 
Panel B shows the results of the second-stage estimation. Columns (1) to (3) employ the baseline mortality instrument where the 
1980 mortality rates are set to zero in all countries. Column (4) assumes that mortality rates fell proportionately in line with the 
global average. In column (5) we assume that mortality rates fell to the level observed in the U.S. in 1980 (the U.S. is dropped 
from the sample for this reason). All regressions include country-sex and year fixed effects. Heteroskedasticity robust standard 
errors clustered at the country-sex level are reported in brackets.  
 
Table 4: Robustness Checks for First-Stage Results 
  (1) (2) (3) (4) (5) (6) (7) 
 Life expectancy at birth 








Mortality -16.101 -14.01 3.808       [5.179] [3.78] [4.814]     Female x Mortality 
 
-8.882 -9.106 -11.813       [7.207] [4.105] [5.414]     Mortality, V-group     -9.863 -9.969 2.221 3.013       [25.31] [2.816] [17.832] [16.603] Female x Mortality, V-group     -45.97 -5.531 -5.502 -7.512       [31.64] [3.250] [1.124] [1.670] Mortality, NV- group     -39.41 -43.496          [31.30] [25.792]    Female x Mortality, NV- group     -8.47 -13.75          [48.97] [39.254]    Residual Mortality -14.105 -13.319 -20.38 -15.22 -20.258 -65.448 -64.957 
  [2.158] [3.391] [2.46] [2.514] [4.408] [35.771] [32.315] 
Observations 300 300 300 300 300 88 88 
Countries 75 75 75 75 75 22 22 
Notes: This table explores the robustness of our first-stage estimates to using different groupings of the mortality rates from the 
infectious diseases and to employing sex-specific mortality data, which are available for a limited sample of 22 countries. The 
specific disease or sub-group of diseases a regression focuses on is indicated at the top of each column. The exact details and the 
rationale behind the different groupings are explained in the text. All regressions include country-sex and year fixed effects, 
except for col. 6 and 7 where we employ separate fixed effects for country, sex and year due to the small sample size. 
Heteroskedasticity robust standard errors clustered at the country-sex level (col. 1-5) or country-level (col. 6, 7) are reported in 
brackets. 
  
Table 5: Robustness Checks for Sub-Samples and Life Expectancy at Higher Ages 

























Panel A: 1st stage results Life expectancy at birth LE at age 5 LE at age 20 
Mortality, V-group -10.059 -11.44 -11.692 -11.672 -4.767 -3.765 
  [2.451] [2.555] [2.507] [2.504] [2.694] [2.323] 
Female x Mortality, V-group -4.853 -5.154 -4.852 -4.623 -5.551 -3.246 
  [2.453] [2.654] [2.437] [2.580] [2.678] [2.216] 
Mortality, NV-group -17.218 -18.758 -21.431 -18.093 -22.467 -17.001 
  [4.665] [4.588] [5.950] [4.692] [12.496] [9.468] 
Female x Mortality, NV-group -5.704 -5.341 -6.569 -5.858 -1.019 -1.003 
  [6.856] [6.811] [9.123] [6.854] [14.961] [11.138] 
Panel B: 2nd stage results Years of schooling 
Life expectancy 0.074 0.115 0.138 0.0991 0.193 0.292 
  [0.0400] [0.0425] [0.0417] [0.0429] [0.0651] [0.0944] 
Observations 280 272 280 268 204 212 
Countries 70 68 70 67 51 53 
1st stage F-statistic 18.69 20.35 22.88 19.26 11.6 7.16 
Notes: This table explores the robustness of our second-stage estimates to changes in the sample composition and employing 
data on life expectancy at higher ages. Col. 1 omits France, Germany, Switzerland, the United Kingdom and the United States. 
Col. 2 omits Algeria, Egypt, Iran, Iraq, Morocco, South Africa, Tunisia. Col. 3 omits Barbados, Belize, Guyana, Jamaica, 
Trinidad and Tobago. Col. 4 omits Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Slovakia, 
Yugoslavia. All regressions include country-sex and year fixed effects. Heteroskedasticity robust standard errors clustered at the 
country-sex level  are reported in brackets. 
 
 
Table 6: Robustness Checks with Alternative Measures of Educational Attainment and Accounting 
for Time Trends 
  (1) (2) (3) (4) (5) (6) 
Panel A: 1st stage results Life expectancy at birth 
Mortality, vaccine group -11.538 -11.538 -11.538 -11.538 -11.52 -11.538 
  [2.41] [2.41] [2.41] [2.41] [2.379] [2.41] 
Female x Mortality, vaccine group -4.959 -4.959 -4.959 -4.959 -4.544 -4.959 
  [2.440] [2.440] [2.440] [2.440] [2.418] [2.440] 
Mortality, non-vaccine group -18.534 -18.534 -18.534 -18.534 -18.282 -18.534 
  [4.588] [4.588] [4.588] [4.588] [4.742] [4.588] 
Female x Mortality, non-vaccine group -5.618 -5.618 -5.618 -5.618 -5.628 -5.618 
  [6.800] [6.800] [6.800] [6.800] [7.11] [6.800] 
Lagged years of schooling      0.582             [0.344]   













Life expectancy at birth 0.114 0.0692 0.0378 0.0561 0.122 0.0317 
  [0.0421] [0.0123] [0.0152] [0.0297] [0.0402] [0.0235] 
Lagged years of schooling      -0.230             [0.153]   
Observations 300 300 300 300 300 300 
Countries 75 75 75 75 75 75 
1st stage F-statistic 22.64 22.64 22.64 22.64 21.86 22.64 
Notes: This table explores the robustness of our second-stage estimates to employing alternative measures of a cohort's level of 
human capital and accounting for time trends in the education data. All regressions include country-sex and year fixed effects. 
Heteroskedasticity robust standard errors clustered at the country-sex level  are reported in brackets. 
 





















Panel A: 1st stage 
results Life Expectancy at Birth 
Mortality, V-group 
-15.670 -9.251 -11.671 -21.125 -17.038 -11.127 -12.589 -10.191 
[2.941] [2.237] [6.231] [9.194] [8.767] [2.575] [2.508] [9.137] 
Female x 
MortalityV- group  
-5.448 -4.959 -4.571 -4.892 -5.954 -4.945 -5.087 -3.942 
[3.033] [2.463] [1.118] [0.910] [1.022] [2.591] [2.168] [1.427] 
Mortality, NV-
group  
-5.060 -14.095 -96.745 -11.444 -22.938 -19.319 -22.36 -455.46 
[13.328] [4.839] [46.318] [38.867] [37.607] [4.868] [4.359] [226.55] 
Female x Mortality, 
NV-group  
-2.753 -5.618 -11.427 -2.360 -6.769 -6.368 -7.330 37.308 
[19.317] [7.719] [12.074] [5.816] [6.550] [7.432] [6.298] [56.073] 
Additional control 
variable  
-1.099 4.982 0.024 0.634 0.803 -0.183 0.033 -0.012 
[1.426] [0.850] [0.036] [0.340] [1.273] [0.079] [0.259] [0.0057] 
Panel B: 2nd stage 
results Years of schooling 
Life expectancy at 
birth 
0.136 0.095 0.212 0.155 0.168 0.194 0.155 0.292 
[0.039] [0.053] [0.047] [0.050] [0.051] [0.029] [0.029] [0.090] 
Additional control 
variable  
1.214 0.578 -0.01 0.112 -0.038 0.0002 -0.085 0.0036 
[0.469] [0.500] [0.009] [0.123] [0.341] [0.023] [0.091] [0.0023] 
Observations 268 300 176 160 160 256 252 84 
Countries 67 75 44 40 40 64 63 21 















1st stage F-stat. 20.91 16.83 28.44 26.11 21.05 18.13 22.23 8.98 
Notes: This table explores the robustness of our main results when considering alternative explanations for the rise in female 
schooling. The regressions include the indicates fixed effects. Heteroskedasticity robust standard errors clustered at the country-
sex or country level (in correspondence with the employed fixed effects) are reported in brackets. 
 
 
Table 8: Effects of Female and Male Health Improvements on per Capita GDP 
Dependent Variable: Log GDP per capita 
  (1) (2) (3) (4) 
Mortality, overall 0.530  0.404   
  [0.153]  [0.144]   
Mortality x post, overall   -0.941       [0.197]   Mortality, V- group  0.213  0.216    [0.235]  [0.212] Mortality x post, V- group    -0.933      [0.297] Mortality, NV- group  2.082  1.329    [0.962]  [0.753] Mortality x post, NV- group    3.264         [13.864] 
Observations 138 138 138 138 
Countries 69 69 69 69 
Within R-squared 0.87 0.87 0.89 0.89 
Notes: This table presents reduced-form estimates of the effects of the predicted mortality reductions from different groups of 
infectious diseases on GDP per capita between 1940 and 1980. All regressions include country and year fixed effects. 
Heteroskedasticity robust standard errors clustered at the country level  are reported in brackets. 
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Section A: List of Countries in our Sample
Main Sample
Our main sample consists of the following 75 countries:
Algeria, Argentina, Australia, Austria, Bangladesh, Barbados, Belgium, Belize, Bolivia,
Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Do-
minican Republic, Ecuador, Egypt, El Salvador, Finland, France, Germany, Greece, Guatemala,
Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Italy, Jamaica,
Japan, Korea, Malaysia, Mauritius, Mexico, Morocco, Myanmar, Netherlands, New Zealand,
Nicaragua, Norway, Pakistan, Panama, Paraguay, Peru, Philippines, Portugal, Poland, Roma-
nia, Russian Federation, Slovakia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan,
Thailand, Trinidad and Tobago, Tunisia, U.S.A., United Kingdom, Uruguay, Venezuela, Viet-
nam, Yugoslavia.
Small Sample
Our small sample consists of the following 22 countries for which we have gender-specic mortality
rates in 1940 from infectious diseases as well as from cancer and cardiovascular diseases:
Australia, Canada, Chile, China, Czech Republic, Denmark, France, Greece, Italy, Japan,
Netherlands, New Zealand, Norway, Portugal, Slovakia, South Africa, Spain, Sweden, Switzer-
land, Taiwan, U.S.A., United Kingdom.
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Section B: Data Description and Sources
This section provides details on all the variables that we employ in our empirical analysis. It
explains how each variable is constructed and based on which sources.
Average years of schooling for each gender and age-cohort are taken from Barro and
Lee (2013). We focus on the cohorts of individuals that were between 5 and 9 years old in the
respective sample years, measured 10 years later. Thus, the 1940 values reect the schooling
levels of the 15-19 years old in 1950, while the 1980 values reect the schooling levels of the 15-19
years olds in 1990.
Primary schooling completion rates are also from Barro and Lee (2013). They corre-
spond to the share of a given schooling cohort that eventually completed primary education. The
respective cohorts we focus on are the individuals that were between the age of 5 and 9 years in
1940 and 1980 respectively, measured 20 years later at the age 25 to 29 years.
Secondary schooling completion rates are also from Barro and Lee (2013). They corre-
spond to the share of a given schooling cohort that eventually completed secondary education.
The respective cohorts we focus on are the individuals that were between the age of 5 and 9
years in 1940 and 1980 respectively, measured 20 years later at the age 25 to 29 years.
Tertiary schooling completion rates are also from Barro and Lee (2013). They correspond
to the share of a given schooling cohort that eventually completed tertiary education. The
respective cohorts we focus on are the individuals that were between the age of 5 and 9 years in
1940 and 1980 respectively, measured 20 years later at the age 25 to 29 years.
Life expectancy at birth in 1940 is primarily based on information reported in the 1948,
1949-1950, 1951 editions and the retrospective section of the 1967 edition of the Demographic
Yearbook published by the United Nations. In all cases we use the data reported in the most
recent edition. These data are supplemented with the information provided by Preston (1975)
and by the Federal Security Agency in their Summary of International Vital Statistics 1937-44.
The respective information for 1980 was obtained from the electronic version of World Population
Prospects of the UN Population Division. As in some cases the available data are not exactly
for the year 1940, we obtain an estimate for 1940 by linearly interpolating the data between
the closest year before and after 1940. For countries that were already involved in World War
II by 1940, we use life expectancy data for the closest available year prior to and after their
involvement in the war and interpolate the value for 1940. This way our life expectancy gures
in 1940 should not reect the e¤ect of the war but the normal mortality environment in each
country.
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Life expectancy at age 5 in 1940 and 1980 are drawn from the same sources as the life
expectancy at birth data. These are specically the UN Demographic Yearbooks for 1940 and
the World Population Prospects database for 1980. Missing values are also interpolated based
on the same procedure.
Life expectancy at age 20 in 1940 and 1980 are drawn from the same sources as the life
expectancy at birth data. These are specically the UN Demographic Yearbooks for 1940 and
the World Population Prospects database for 1980. Missing values are also interpolated based
on the same procedure.
Mortality rates in 1940 by disease are obtained from Acemoglu and Johnson (2007), who
report mortality rates separately for 13 infectious diseases. For the year 1980, we do not use
actual mortality rates, but predicted ones. Following Acemoglu and Johnson (2007) we take
the 1980 mortality rates from all infectious diseases to be zero. This way our mortality variable
does not reect the actual changes in mortality rates in each country, but the predicted changes
resulting from the introduction of the new medical technologies that provided e¤ective control
of infectious diseases. We furthermore construct two alternative variants of this variable where
the predicted mortality rates in 1980 are based either on U.S. mortality rates in 1980 or on the
country-specic rates in 1940 scaled down by the average rate of decline in mortality from the
respective diseases observed at the global level.
Overall mortality correspond to the sum of the predicted mortality rates from the 13
infectious diseases. In our baseline setup this value is zero in 1980 by construction.
Mortality from vaccine-preventable diseases (V-group) corresponds to the sum of the
mortality rates from the following seven diseases: diphtheria, inuenza, measles, pneumonia,
smallpox, tuberculosis, whooping cough. In our baseline setup this value is zero in 1980 by
construction.
Mortality from non-vaccine-preventable diseases (NV-group) corresponds to the sum
of the mortality rates from the following six diseases: cholera, malaria, plague, scarlet fever,
typhoid fever, typhus. In our baseline setup this value is zero in 1980 by construction.
Mortality from the 10 remaining diseases correspond to the sum of the mortality rates
from the following ten diseases: cholera, diphtheria, inuenza, measles, plague, scarlet fever,
smallpox, typhoid fever, typhus, whooping cough. In our baseline setup this value is zero in 1980
by construction.
Mortality from bacterial diseases correspond to the sum of the mortality rates from
the following nine diseases: cholera, diphtheria, plague, pneumonia, scarlet fever, typhoid fever,
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tuberculosis, typhus, whooping cough. In our baseline setup this value is zero in 1980 by con-
struction.
Gender-specic mortality rates in 1940 are from Preston et al. (1972). They are available
for the above-mentioned 22 countries of the small sample. The authors provide information on
11 distinct mortality causes, not all of which are infectious diseases. Based on this information
we construct mortality rates for a group of vaccine-preventable infectious diseases that includes
inuenza, pneumonia and tuberculosis and a residual group of infectious diseases. As the reported
mortality rates do not always correspond exactly to the year 1940, we interpolate the missing
values between the closest year available before and after 1940 assuming a linear trend. For 1980
we assume again that the mortality rates for both groups of diseases were zero.
GDP per capita data are taken from the Maddison Project. For the countries for which
data are not available in 1940 we interpolate the missing values assuming a constant growth rate
between the years for which data are available.
Womens voting rights are measured with a dummy variable which is coded as 1 if women
had the right to vote in a given country and year and zero otherwise. The coding of this variable
is based on the information provided in Ramirez et al. (1997) who document for 133 countries
between 1890 and 1990 when women acquired su¤rage.
Labor force participation rates for 1940 correspond to the activity rates relative to the
overall population and come from the 1948 and the 1949-1950 editions of the UN Demographic
Yearbook. In cases where data for the year 1940 are not available, we use the data for the
year closest to 1940. In most cases, this is the year 1941. The rates for 1980 are based on
information reported in the electronic database of labour statistics of the International Labour
Organization (ILOSTAT). As the database reports activity rates relative to the working-age
population, we make these rates comparable to the 1940 rates by converting them to shares of
the overall population. We do so by using the corresponding population data from the World
Population Prospects database.
Average age at marriage data for the male and female population are constructed based
on the information reported in the UN Demographic Yearbook on the number of marriages by
age of the bride and groom. The 1940 data are based on information reported in the 1948,
1949-50 and 1958 editions of the Yearbook, while the 1980 values are based on the 1982 edition.
If information in the exact years of interest is not available, we use the data in the years closest
to 1940 and 1980 respectively. As the data are typically reported for 5-year age groups, running
from the age of 15-19 years onward, we take the mid point of each age bracket and calculate
the average age based on that. For marriages that take place in the last age group, 60 plus, we
assume that they happen at the age of 62.
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Average age di¤erence at marriage between men and women is calculated as the di¤er-
ence between the average age of the bride and that of the groom. The underlying data are the
average age at marriage data described above.
Fertility rates are measured as the number of life births per 1,000 individuals. The data
for 1940 come from the 1949-1950 edition of the UN Demographic Yearbook. The 1980 values
are taken from the 1981 edition of the UN Demographic Yearbook.
Maternal mortality rates in 1940 are taken from World Health Organization (1951), Fed-
eral Security Agency (1947) and the 1951 and 1957 editions of the UN Demographic Yearbook.
In case of revisions in the UN data, we use the most recently reported data. Missing values
are interpolated using the two closest data points before and after 1940 assuming a linear time
trend. The 1980 mortality rates are taken from the 1981, 1982, 1983 and 1985 editions of the
UN Demographic Yearbooks. Data are available for 63 out of the 75 countries in our data set
and are by denition zero for the male population.
Mortality rates from cancer and cardiovascular diseases in 1940 are taken from Pre-
ston et al. (1972) and are available for 21 countries. Missing values are interpolated using the two
closest data points before and after 1940 assuming a linear time trend. The corresponding 1980
gures are taken from the 1981, 1982, 1983 and 1985 editions of the UN Demographic Yearbook.
The Post-demographic transition dummy is coded based on the criteria provided by
Cervellati and Sunde (2011). Specically a country is classied as having gone through the
demographic transition if by 1940 life expectancy at birth exceeded 50 years, there was a sus-
tained decline in fertility, or the crude birth rate had fallen below 30/1000. Based on this
classication the post transitional countries consist of Argentina, Australia, Austria, Belgium,
Bulgaria, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ice-
land, Ireland, Italy, Japan, Netherlands, New Zealand, Norway, Poland, Portugal, Romania,
Russian Federation, Slovakia, Spain, Sweden, Switzerland, U.S.A., United Kingdom, Uruguay,
Yugoslavia.
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Section C: Disease Classication
As part of our analysis we classify the di¤erent infectious diseases into two groups: a group
of vaccine-preventable diseases (V-group) and a group of non-vaccine-preventable diseases (NV-
group). We perform this classication based on specic information regarding the nature of each
disease and the medical breakthroughs related to its treatment that took place as part of the
international epidemiological transition.
Cholera: Cholera is an acute diarrheal disease caused by the bacterium Vibrio cholerae and is
spread by drinking contaminated water or eating contaminated food. The rst e¤ective vaccine
against cholera was developed in 1896 by Wilhelm Kolle. However, the vaccines available since
then, including the modern ones developed in the 1990s, provide only limited immunity. This is
typically for no more than one year (Parish, 1965; WHO, 2010). The most important mechanism
for controlling cholera is the provision of clean drinking water and improved sanitation. Since
cholera-induced diarrhea results in severe dehydration within 3-4 hours, the development of more
e¤ective oral rehydration therapy in the 1950s provided a major breakthrough in the treatment
of cholera. Furthermore, antibiotics developed in the 1940s shorten the course of the disease and
reduce the symptoms (Kiple, 2003). We, thus, code cholera as a non-vaccine-preventable disease
given the ine¤ectiveness of the available vaccines.
Diphtheria: Diphtheria is caused by the Corynebacterium diphtheriae and is spread by air
or touch. Kitasano and Behring developed in 1890 the rst antitoxin from the serum of animals
that had been infected with the toxins secreted by the bacilli. They showed that this antitoxin
could be used to treat diphtheria patients. In 1913 Behring reported rst trials of successful
immunization with toxin-antixtoxin mixtures (Baker and Katz, 2004). However, even though
toxin-antitoxin mixtures had been successfully used for vaccination in some U.S. cities in the
1920s, it was generally di¢ cult to employ these mixtures. This was because it was unclear how
toxins and antitoxins should be balanced to induce an e¤ective and at the same time safe immu-
nization (Kiple, 2003). The key event in the development of safe vaccines was the development
of a chemically modied toxin, called toxoid, by Leon Ramon of the Pasteur Institute. By using
heat and formalin, the toxins toxicity was reduced without a¤ecting its immunizing power. This
vaccine was approved for children in France in 1927 and made compulsory for children in France
in 1938 (Parish 1965), but in other countries the vaccine was only adopted much later. Mass
immunization at the global scale did not start until after World War II and after the licensing
of the combined diphtheria-tetanus vaccine in 1947 (Baker and Katz, 2004). Large-scale vac-
cinations were further improved and facilitated with the development of the jet injector in the
1960s and the invention of freeze drying during WWII, which greatly increased the storability of
vaccines and facilitated vaccine transportation (Kiple, 2003). Given that large-scale immuniza-
tion campaigns outside of France did not start before the mid 1940s, we code diphtheria as a
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vaccine-preventable disease.
Inuenza: Inuenza is caused by three strands of the inuenza virus, types A, B, and C. It
is passed by breath-born droplets, such as sneezing and coughing. The type A virus was rst
isolated and identied in 1934 and type B in 1940 (Kiple, 2003). The rst vaccine was developed
during World War II to protect soldiers and production was expanded to civilian markets in 1946
(Hoyt, 2006). While the development of antibiotics in the 1940s also played a role in reducing
mortality from secondary bacterial infections, the primary control mechanism for inuenza is
vaccination. Hence, we place inuenza in the group of vaccine-preventable diseases.
Malaria: Malaria is caused by parasites transmitted by the female mosquito of the Anopheles
type. The causal parasites were identied and the role of the Anopheles mosquito established in
the 1890s. Since then the strategy generally applied to control malaria has been the control of
mosquitoes. This became much more e¤ective with the discovery of DDT residual insecticides
in the late 1940s (Kiple, 2003). E¤ective vaccines still do not exist to this date. Given this, we
assign malaria to the group of non-vaccine-preventable diseases.
Measles: Measles are a viral infection, principally occurring among children. The disease is
transmitted by air and through touch. Measles vaccines were rst produced in 1958 and licensed
in 1963. A single dose of the measles virus vaccine provides life-long immunity in over 95% of
cases (Kiple, 2003). First steps in the development of the measles vaccine were the discovery
that the disease was caused by a virus in 1911. Yet, the isolation of the measles virus did not
occur until 1954. Thus, we assign measles to the group of vaccine-preventable diseases.
Plague: Plague is caused by the bacterium Yersinia pestis and is transmitted to humans
through the bite of infected eas. First vaccines were developed in the late 1890s, but the
exact nature of the disease and the role of the ea in transmitting the disease from infected
rats and other wild rodents were not fully studied until 1914 (Parish, 1965). After this was
established, the elimination of rats and eas became the key step in the prevention of plague.
While vaccines developed in the 1890s were e¤ective in reducing incidences of plague and plague
mortality, protection only lasted for a few months (Parish, 1965). With the development of
antibiotics, especially streptomycin, in the 1940s, vaccination became of secondary importance
(Kiple, 2003). Given the limited protection vaccines a¤orded and the fact that they had been
available since the 1890s, we code plague as a non-vaccine-preventable disease.
Pneumonia: Pneumonia is caused by a variety of infectious agents, including viruses and
bacteria. For viral pneumonia, viral vaccines, in particular inuenza vaccines developed in the
1940s, are e¤ective in preventing infections (Ruuskanen et al., 2011). These became available for
civilian markets in 1946 (Hoyt, 2006). For bacterial pneumonia, which is caused by the bacterium
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Streptococcus pneumoniae, both vaccines and antibiotics have been used for disease control.
Specically, the bacterium was rst isolated by Louis Pasteur in 1880 and the identication of
other causative agents followed gradually. Vaccines against bacterial pneumonia became rst
available 1945, but since the discovery of penicillin and other antibiotics they were not widely
used and not further developed (Kiple, 2003). This is because antibiotics were more e¤ective
than the original vaccines for treating and reducing mortality from bacterial pneumonia. Vaccines
against bacterial pneumonia, however, were further developed in the late 1970s and early 1980s.
This resulted in the licensing of more e¤ective vaccines in 1977 and 1983, the nal breakthrough
being the development of pneumococcal conjugate vaccines in 2000 (Klein and Plotkin, 2007).
We assign pneumonia to the vaccine-preventable diseases, as key vaccines became available in
the 1940, albeit only partially e¤ective ones.
Scarlet Fever: Scarlet fever is caused by certain strains of group A Streptococcus bacteria.
The bacteria were rst isolated in 1887. E¤orts to produce a streptococcus vaccine followed, but
the results were not convincing. To this date no e¤ective vaccine exists. However, the disease
is e¤ectively treated with antibiotics, including penicillin, developed in the 1940s (Kiple, 2003).
Given this, we assign scarlet fever to group of non-vaccine-preventable diseases.
Smallpox: Smallpox was an infectious disease caused by the viruses Variola major and Variola
minor. An e¤ective vaccine was developed in 1798 by Edward Jenner, which was derived from
cowpox, a related disease found among animals (Kiple, 2003). However, large-scale immunization
was not possible until the 1950s when free-drying, invented in the 1940s, was adopted for mass
production of vaccines (Fenner, 2011). Until then the storability of the vaccine was very limited
and temperature uctuations frequently caused the vaccine to lose its potency. The invention of
the jet injector in the 1960s was another important development that signicantly facilitated the
administration of the vaccine. The combination of these technologies resulted in the eradication
of the disease by the late 1970s. We, therefore, assign smallpox to the vaccine-preventable
diseases.
Tuberculosis: Tuberculosis is caused by the bacterium Mycobacterium tuberculosis and is
transmitted through air. The bacterium was discovered in 1882 by Robert Koch. The rst
e¤ective vaccine was developed by the French Pasteur Institute and became available for use in
1921 (Parish, 1965). This is the BCG (Bacille Calmette Guerin) vaccine which is still in use
today. However, mass immunization did not start until after the late 1940s when UNICEF in
cooperation with the Danish and Swedish Red Cross teams started mass immunization campaigns
(Kiple, 2003). Until then, the vaccine had been primarily used in France where by 1933 about
20% of all children were vaccinated. Outside of France, though, only 500,000 children had been
vaccinated at that time (Parish, 1965). This changed with the mass post-war immunization
campaigns. In 1948-1951 alone 30 million people were tuberculin tested and 14 million were
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vaccinated. The campaign was extended further under a joint UNICEF/WHO initiative which
led to the vaccination of an additional 60 million people by 1956 (Comstock, 1994). Given the
sensitivity of the BCG vaccine to sunlight and temperature uctuations and the fact that it could
only be stored for 10 days after initial preparation (Bonah, 2005), the invention of freeze-drying
in the 1950s provided another major step forward in the ght against tuberculosis (Parish, 1965).
It allowed for the vaccine to be stored under various climatic conditions for prolonged periods of
time and to be transported easily over long distances. In addition, drugs developed in the 1940s
and 1950s, in particular streptomycin in 1944, provide e¤ective treatment and made most cases
of the disease curable. Given that mass immunization campaigns did not start before the late
1940s, we code tuberculosis as a vaccine-preventable disease.
Thyphoid Fever: Typhoid fever is caused by the bacterium Salmonella typhi and is spread
through contaminated water or food. Vaccines were developed before World War I, but they were
not very e¤ective. With the introduction of antibiotics in the 1940s, which provided e¤ective
treatment, the use of vaccines became of secondary importance in the control of the disease
(Kiple, 2003). Hence, we code typhoid fever as a non-vaccine-preventable disease given that
vaccines had already been available long before 1940 and were not very e¤ective.
Typhus: Typhus is caused by Rickettsia bacteria transmitted by the human body louse
Pediculus humanus corporis. The role of the louse was established in 1909 and the bacterium
rst demonstrated in 1916 (Parish, 1965). Public health measures such as good hygiene and
sanitation played an important role in the control of the disease. First attempts in developing
a vaccine to be used in humans were made in the 1930s. This was in the form of the Weigl
vaccine, which used killed bacteria, and the Cox vaccine, which used live bacteria (Lindenmann,
2002). They were albeit di¢ cult to manufacture and turned out to not be very e¤ective. With the
introduction of antibiotics, which provides e¤ective treatment for typhus, and the development of
DDT, which allowed for very e¢ cient delousing, vaccines fell into disuse (Lindenmann, 2002). We
assign typhus to the non-vaccine-preventable diseases given that vaccines were already available
before 1940 and not much used after the introduction of broad-spectrum antibiotics.
Whooping Cough: Whooping cough, or pertussis, is caused by the bacterium Bordetella
pertussis and occurs primarily among young children. The causative agent was rst isolated in
1900 and the rst e¤ective vaccine was developed in the 1930s. There had been earlier attempts
already in the 1920s to develop a pertussis vaccine. However, these early vaccines had very limited
e¢ cacy and became obsolete with the introduction of the vaccines developed by Kendrick and
Eldering (Parish, 1965; Granstroem, 2011). First large-scale clinical trials were conducted in
the U.S. in the late 1930s and early 1940s, which demonstrated the e¤ectiveness and safety
of the vaccine (Parish, 1965). Following that, the American Academy of Pediatrics approved
the vaccine for routine use in 1943. However, it was not until the later 1940s that pertussis
10
vaccines were widely used when the combination vaccine with diphtheria and tetanus, DPT, was
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